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Supervisors: Associate Professor Anne-Kari Torgalsbøen and Post-doctoral Research Fellow 
Christine Mohn. 
Background: The concept of recovery in schizophrenia has been reformed to include, in 
addition to symptom remission, social function, role functioning and daily functioning. 
Persons who have recovered from schizophrenia have published accounts of what has been 
important for them in their way to recovery. The perceiving of and dynamic interaction with 
situations, relations and self has been found to be important in a recovery process that enables 
hopes for a future that is valuable. These relations are integrated in the concept of resilience, 
which is defined as a positive outcome in psychological wellbeing despite the adversity of 
schizophrenia. The purpose of this thesis is to investigate whether there is a statistically 
significant relationship between degrees of resilience and symptom remission. The 
conceptualisation of resilience as both a trait and a process in schizophrenia is addressed. An 
additional aim is to find out if degrees of resilience are predictive for symptom remission in 
schizophrenia. Relations that foster symptom remission are important to investigate, as it is 
estimated that one per cent of the population have a diagnosis within the schizophrenia 
spectrum, and life courses involving schizophrenia are found to involve diverse adversities. 
Methods: Measures of perceived resilience, hope and perceived self-efficacy were 
administered by the principal researcher to a group of 28 young adults with a recent debut of 
schizophrenia over a period of two years. Ratings of positive and negative symptoms were 
assessed by the principal researcher according to the Positive and Negative Symptoms Scale 
during the first year and at 2-year follow-up.  
Results: Significant results on the relationship between resilience and symptom remission 
were found. Significant and non-significant results on correlations between different 
assessments of resilience found resilience to be conceptualised as both traits and processes. 
Investigation of predictive value of resilience on symptom remission found that high levels of 
experienced resilience are more than 13 times as likely to predict symptom remission at 2-
year follow-up.  
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Conclusions: Despite the low number of participants in this study, statistically significant 
results between resilience and symptom remission were found. Experienced resilience is 
found to be conceptualised as traits and processes. It is demonstrated that high degrees of 
resilience are predictive for symptom remission. These results suggest that focusing on 
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1.1  Schizophrenia. 
Schizophrenia is an illness that, according to researchers, has always been present in the 
population, but it was first in the nineteenth century that the illness was systemised. The first 
description of what we would call schizophrenia today was made by Doctor of Medicine John 
Haslam in 1809, he described a casus he would classify as “a form of insanity that occurs in 
young persons” (Malt, Dahl, & Retterstøl, 2003, p. 194) In 1896 Professor of Clinical 
Psychiatry Emil Kraepelin gathered the existing diagnostic categories of hebephrenia, 
catatonia, and paranoid psychosis by using the term “dementia praecox”  (Cutting & 
Shepherd, 1987, p. 13) Psychiatrist Eugen Bleuler modified the diagnostic formulation in 
1911 and called “dementia praecox” for  “Die Gruppe der Schichophrenien” (Cutting & 
Shepherd, 1987, p. 59) For as long as the phenomena of schizophrenia has been known, there 
has been a continuous debate on how schizophrenia should be classified (Malt et al., 2003). In 
DSM-III a broad definition of schizophrenia was replaced to one of the narrowest concepts of 
the phenomena. As cited in Torgalsbøen (2011), Warner and de Girolam (1994) found that for 
every person with a narrowly-defined diagnosis of schizophrenia, there are four other persons 
in the population that are classified to be in the broader-defined diagnosis of schizophrenia 
(Torgalsbøen, 2011). A new view on this topic is included in DSM-V with the organising of 
Schizophrenia Spectrum and Other Psychotic Disorders (DSMPsychiatryOnline, 2014). In 
total, one per cent of the population has a lifetime risk of developing schizophrenia 
(Andreassen & Steen, 2011). 
1.1.1 Positive symptoms, negative symptoms and neurocognition. 
Several studies (Liddle, 1987, Mueser, Curran & McHugo, 1997,and Van der Does, 
Dingemans, Linszen, Nugter & Scholte, 1993) on the dimensions of schizophrenia agree on at 
least three major groups of symptoms, including positive symptoms, negative symptoms and 
cognitive impairments (Hersen, Turner, & Beidel, 2007). Many researchers have tried to 
identify two types of schizophrenia, one type with mainly positive symptoms and one type 
with mainly negative symptoms. Categorizing in two categories has been difficult since the 
symptoms often fluctuate (Malt et al., 2003).  Positive symptoms refer to thoughts, sensory 
experiences and behaviors that are absent in persons without the illness but present in persons 
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with schizophrenia. Common examples include hallucinations (e.g. hearing voices, seeing 
visions), delusions (e.g. believing that people are persecuting the person) and bizarre, 
disorganised behavior (e.g. maintaining a peculiar posture for no apparent reason). The 
positive symptoms of schizophrenia tend to fluctuate over the course of the disorder and are 
often in remission between episodes of the illness (Hersen et al., 2007).  Negative symptoms 
refer to the absence or diminution of cognition, feelings or behaviors which are normally 
present in persons without the illness. Common negative symptoms include blunted or 
flaunted affect, poverty of speech, anhedonia (inability to experience pleasure), apathy, 
psychomotor retardation and physical inertia. Cognitive impairments refer to difficulties in 
verbal and visual learning and memory, working memory, attention or vigilance, abstract 
reasoning or executive function and speed of information processing (Hersen et al., 2007). 
Rund and collaborators (2005) found in the Bergen Oslo-project that approximately one out of 
three patients with schizophrenia is cognitively unaffected. They found that 45 per cent had 
mild cognitive impairments and that 15 per cent had extensive cognitive impairments (Sundet, 
2011). Research has shown that cognitive impairment is an important aspect regarding 
schizophrenia, either the impairment exists before, parallel or is developing after the debut of 
symptoms (Sundet, 2011). 
1.1.2 Comorbidity  
As cited in Hersen (2007), Turner & Beidel (2008), Freeman & Garety (2003) found that 
aside from the core symptoms of schizophrenia, many persons with a schizophrenia diagnosis 
experience negative emotions (e.g. depression, anxiety, anger) as a consequence of their 
illness (Hersen et al., 2007). Depression is quite common with a comorbidity rate of 45% 
(Leff, Tress, & Edwards, 1988). Several studies (Argyle, 1990, Braga, Mendlowicx, Marracos 
& Fugueria, 2005, Cosoff & Hafner, 1998, Penn, Hope, Spaulding & Kucera, 1994, and Tien 
& Eaton, 1992) have found that anxiety is common in schizophrenia with an estimated 
comorbidity of 43%, and is a frequent precursor for psychosis (Hersen et al., 2007). 
Approximately 50% of all persons with schizophrenia diagnosis have a lifetime history of 
substance use disorder, and 25% to 35% cent have a recent history of such a disorder 
(Mueser, Bennett, & Kushner, 1995). Several studies (Bromet, Fochtmann, Carlson & 
Tanenberg-Karant, 2005, Drake, Gates, Whitaker & Cotton, 1985, Jobe & Harrow, 2005 and 
Roy, 1986) have reported that it is generally estimated that approximately 10% of persons 
with the illness die from suicide (Hersen et al., 2007). Recent research carried out by Palmer, 
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Pankratz & Bostwick (2005) (Inskip; Harris & Barraclough, 1998) examining suicide rates 
has lowered this estimate to around 4.0% to 5.6% (Hersen et al., 2007). 
1.1.3 Course and prognosis 
Kraeplin viewed schizophrenia as a latent factor in the individual that can improve but which 
always reverts. He stated in 1896 “The course of dementia is generally regular and 
progressive. It is rare to see a substantial remission of the symptoms; at least the excitement 
disappears, but the mental impairment remains. On the other hand, it is fairly common to find 
patients who are calm, whose condition has “improved”, but who revert even after years to a 
state of excitement” (Le & Urgård, 2011, p. 1) Both Kraeplin and Bleuler considered 
remission to be possible, but this was only temporarily. Kraeplin viewed recovery as a 
temporary remission, and Bleuler viewed remission as a residual state. Bleuler noted in 1908: 
“In schizophrenia there is no cure in the sense of restitutio ad integra, (…). Whenever I have 
been able to examine any of those who have been pronounced cured I have found a residue of 
the illness” (Le & Urgård, 2011, p. 1) Kraeplin reported in 1904 that 8% to 13% of his long 
term in-patients recovered and 17% of the patients improved from the illness on the long 
term. Clinicians at his time did not approve the studies and called it wrongly diagnosed 
“dementia praecox” (Le & Urgård, 2011). 
The pessimistic view on the prognosis of schizophrenia and recovery persisted up until the 
Diagnostic and Statistical Manual of Mental Disorders IV (DSM-IV). As cited in Torgalsbøen 
(2011), DSM-III stated that if the person with a schizophrenia diagnosis functioned on a 
premorbid level, it was necessary to question the original diagnosis. This view was modified 
in DSM-IV were it was stated that full recovery is possible, but not normal (Torgalsbøen, 
2011). Today, DSM-V states that: “The course appears to be favorable in about 20% of those 
with schizophrenia, and a small number of individuals are reported to recover completely” 
(DSMPsychiatryOnline, 2014) The term “recover completely” is not defined, nor is “a small 
number of individuals”, which gives a more pessimistic impression of recovery from the 
illness than is reported from research.  
Several studies (Bleuler, 1972, Ciompi and Müller, 1976, DeSisto, Harding, Ashikaga, 
McCormick and Brooks, 1985, Harding, Brooks, Ashikaga, Strauss and Breier, 1987, 
Hinterhuber, 1973, Huber, Gross and Schüttler, 1979, Kreditor, 1977, Marinow, 1974, 
Ogawa, Miya, Watarai, Nakazawa, Yuasa and Utena, 1987, Tsuang, Woolson and Fleming, 
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1979 and Harrow and Jobe, 2010) have shown that sustained remission and full recovery is 
possible in more individuals than suggested by the latest version of DSM (Ciompi, Harding, 
& Lehtinen, 2010). Ciompi, Harding and Lehtinen (2010) commented their deep concern 
regarding the pessimistic view on recovery from schizophrenia and stated that findings from 
these convergent 11 world studies of 20 – 30 + years from first admission “have consistently 
shown that persons labeled with prolonged and episodic forms of schizophrenia have a strong 
possibility of favorable long-term outcomes if given half a chance” (Ciompi et al., 2010, p. 
437). Today there is common knowledge between researchers that 20% to 25% of patients 
diagnosed with schizophrenia obtain full recovery from the illness. Full recovery is here 
defined as being absent of symptoms or to have minimum levels of symptoms over a longer 
period of time and to have a good social and role-functioning (Harding, 1994; Warner, 1994). 
Full recovery is no longer viewed as a temporary state but as a stable state. The symptom 
criteria for remission from schizophrenia is in this thesis defined as being absent or having a 
minimum of symptoms in a period of six months. Full recovery is in the study this thesis is 
based on defined as absence or minimum of symptoms over two years, to have a good social 
function, a good role function and to be able to take care of day-to-day needs (Andresen, 
Oades, & Caputi, 2003; Kay, Flszbein, & Opfer, 1987). Being in remission is part of and a 
predictor for full recovery as absence or having a minimum of symptoms is part of being fully 
recovered from this illness. The 11 world studies have shown that recovery and full recovery 
can be found in 46% to 68% of persons diagnosed with schizophrenia, which gives a more 
positive outlook for the prognosis (Torgalsbøen, 2011).   
1.1.4 Vulnerability and schizophrenia 
Today there is a new view on remission and full recovery in schizophrenia. Zubin et al 
described the phenomena in the following way in 1977: “The one feature that all 
schizophrenics have in common is not the ever presence of their illness, but rather the ever 
presence of their vulnerability” (Zubin & Spring, 1977, p. 204). The vulnerability construct is 
differentiated in the two components inborn and acquired vulnerability. Inborn vulnerability 
consists of genes and is reflected in the internal environment and neurophysiology of the 
individual. The acquired component is due to the influence of traumas, specific diseases, 
perinatal complications, family experiences, adolescent peer interactions, and other life events 
that either enhance or inhibit development of a following disorder (Zubin & Spring, 1977). 
The two components of vulnerability may be defined as traits and processes.   
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Figure 1: Low levels of vulnerability, good premorbid adjustment and a supportive environment correlate 
negatively with episodes of relapse.   
 
Vulnerability is found in higher or lower levels in every individual and under suitable 
circumstances and these levels were suggested to be able to express themselves in episodes of 
schizophrenia. Persons were suggested to have different coping abilities, a coping breakdown 
may open the way for the eruption of a psychological disorder (Zubin & Spring, 1977). 
Maintenance treatment (Goldberg, Schooler, Hogarty, & Roper, 1977) and follow-up studies 
(Jablensky, Sartorius, Gulbinat, & Ernberg, 1981) had found that a pattern of disorder 
succeeded by cycles of improvement and relapse. On the basis of these studies Zubin and 
Spring (1977) further noted that some persons with schizophrenia have high levels of 
vulnerability while others have low levels of vulnerability, they found that degree of 
vulnerability has an effect on episodes with relapse. The persons who relapse are suggested to 
return to hostile environments (Jablensky et al., 1981; Zubin & Spring, 1977). Later studies 
have supported the view that hostile environments have an effect on relapses (MacMillan, 
Gold, Crow, Johnson, & Johnstone, 1986; van Zelst, 2009) and that vulnerability is a present 
quality of persons with former schizophrenia diagnoses (Torgalsbøen & Rund, 2010). As 
cited in, Ciompi and collaborators, the 11 world studies have shown high recovery rates 
(Ciompi et al., 2010) that supports the view of traits and processes of vulnerability. Zubin and 
Spring defined vulnerability as an enduring personality trait which makes an empirical 
probability that the individual will experience an episode of mental disorder. On the basis of 
diverse findings  Zubin and Spring noted that the good premorbid patient often returns to his 
formerly good adjustment whereas the poor premorbid patient often returns to his poor 












adjustment (Zubin & Spring, 1977). The coherences between the processes with the 
environment and traits for vulnerability are described in figure 1.  
1.2 Resilience and schizophrenia 
Disease and vulnerability has been a focus in general mental health (Campbell-Sills, Cohan, 
& Stein, 2006) and schizophrenia (Torgalsbøen, 2011). Too only have a focus on disease and 
vulnerability is a one-sided focus, focusing on positive adaption; resilience, is needed to make 
delicate distinctions (Torgersen & Waaktaar, 2012) which can prosper a differentiated picture 
of different illnesses. Adverse experience may also foster subsequent with resilience, with 
resulting advantages for mental health and well-being (Seery, Holman, & Silver, 2010). Traits 
and processes which enables these relations, have been vastly understudied compared to 
disease and vulnerability (Campbell-Sills et al., 2006), to study these relations are therefore 
suggested to be important in the field of schizophrenia as it can contribute to a richer picture 
on what prosper recovery. To differentiate the illness from the personality and find positive 
attributes, with the help of treatment, have been found awarding for persons with a 
schizophrenia diagnosis (Torgalsbøen, 2012b). The persons with a former schizophrenia 
diagnosis have here described the importance of processes and personal abilities which 
prospered a hope for a valuable future. Rustøen and collaborators (2003) have found that an 
individual’s subjective view of health is a more important predictor of hope, than the presence 
of chronic disease itself (Rustøen et al., 2003)), to investigate if this relation is present in 
schizophrenia would be interesting. 
1.2.1 The construct of resilience 
In the mid 1950’s researchers discovered that there are big individual differences in how well 
persons adjusts after experiencing the same type of adversity. It was the understanding of this 
phenomena that put focus on the children that adjusted well, instead on focusing on 
maladaptive adjustment. The concept of resilience emerged (Bekkhus, 2012). Luthar, 
Cicchetti, & Becker (2000) summarized the resilience research since the early 1990s, and 
found that the focus of resilience research has shifted away from identifying protective factors 
to understanding the process through which individuals overcome the adversities they 
experience (Luthar, Cicchetti, & Becker, 2000). There are many definitions of the phenomena 
and Dr. George Vaillant summarized the concept of resilience well in 1993: “We all know 
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perfectly well what resilience means until we listen to someone else try to define it.” Drs. 
Steven and Sybil Wolin noted in 1994 that “Perhaps resilient children are, in the words of Dr. 
Norman Garmezy, "the keepers of the dream," our best hope for learning how to use the 
lessons of the past to help ourselves in the present.” (Juvenilecouncil, 1999a, 1999b) 
Resilience is described as a personality trait, a dynamic process and an outcome (Fletcher & 
Sarkar, 2013). Windle (2011) noted that an important debate emerging from the literature 
concerns the conceptualisation of resilience as either a trait or a process (Windle, 2011). The 
word resilience originates from the Latin verb “resiliere”, or to “leap back”. The term 
resilience has roots in mathematics and physics. As cited in Fletcher and Sarkar (2013), 
Lazarus (1993) cited the example of elasticity in metals, with a resilient metal bending and 
bouncing back (instead of breaking) when stressed. Most definitions of psychological 
resilience emphasize both adversity and positive adaption. (Fletcher & Sarkar, 2013). Borge 
(2007) makes a distinction between resilience and resilient. Resilient refers to what is in the 
person, whereas resilience is about complex interaction between the person and environments 
with adversity. Resiliency is an expression used to describe the phenomena of children 
developing a more secure and confident personality because they acquire social experiences 
which enhance the positive attributes of the child (Borge, 2007). Resiliency can be viewed as 
an outcome of a resilience process with the use of social relations, whereas resilient may refer 
to an underlying personality trait. Transferred to schizophrenia in adults, different persons 
with schizophrenia can have lesser or richer degrees of resilient traits. The adversity and 
managing this with a positive outcome as the result refers to resilience, where richer resilient 
persons make better use of their traits and the support provided. Resiliency is obtained when 
the person has made use of his or her attributes and overcomes adversity; they have acquired 
techniques that make them confident that they can handle obstacles in the future. Borge 
(2007) emphasizes that the expression “bouncing back” can give a false impression of 
resilience, it is rather a quality to be able to come back to a level of homeostasis than a 
phenomena that happens just once (Borge, 2010). Resilience conceptualised as traits, enable 
the individuals to adapt to the circumstances they encounter (Connor & Davidson, 2003; 
Sarkar & Fletcher, 2014), whereas the process conceptualisation recognizes that it is a 
capacity that develops over time, in the context of person-environment interactions (Egeland, 
Carlson, & Sroufe, 1993; Sarkar & Fletcher, 2014) Resiliency includes a quality of an 
outcome, whereas resilience processes and traits interacting with each other in a continuously 
manner, is suggested to be called experienced resilience. 
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The four waves of resilience 
It has been four waves in the understanding and conceptualisation of resilience. The first wave 
identified resilient qualities in the individual and in the systems around, to predict social and 
personal success. The second wave emphasized the processes of coping with stressors, 
adversities, change or opportunity in a manner that resulted in identification and enrichment 
of protective factors (Richardson, 2002). A model containing outcomes of resilient 
reintegration (e.g. higher levels of homeostasis), reintegration back to comfort zones or 
reintegration with loss was made (Richardson, Neiger, Jensen, & Kumpfer, 1990). The third 
wave had a focus on identifying motivational forces within the individuals and groups, and 
the creation of experience that foster the activation and utilization of these forces. This wave 
helped clients discover and apply the force that drives a person toward self-actualization and 
to resiliently reintegrate from disruptions (Richardson, 2002). Masten and Obradovic (2006) 
have identified a fourth wave of resilience, where there is offered an intriguing possibilities 
for a deeper understanding of how processes work within and across levels to understand 
resilience (Masten & Obradović, 2006). As cited in Bekkhus (2012), Rutter (2007) 
emphasizes that an individual can be resilient to a given factor or a given outcome, but not to 
others (Bekkhus, 2012). Some situations might be more challenging for some individuals 
even though their degree of resilience is high, the obstacles at hand may be too big and 
despite resilience factors, the individual does not overcome the adversity at hand. Transferred 
to schizophrenia, individuals with schizophrenia might be high on resilient traits but do not 
overcome the adversity of the psychosis, and maintain low levels of homeostasis. Persons 
with schizophrenia might overcome the diagnosis itself, but may suffer of low levels of 
homeostasis hence other adversities such as depression and anxiety in the long term. Life 
situations with diverse adversities make it difficult to isolate the impact associated with any 
single event, especially over a lifetime with many adversities. Life situations with adversities 
may enable cumulative effects, as the person can be resilient to one adversity and not to others 
(Seery, Holman, & Silver, 2010), and if an adversity is occurring when less resilience is 
experienced, negative cumulative processes are suggested to have a heightened chance to 
occur. Schizophrenia is a diagnosis correlated with diverse adversities; violence, drug abuse, 
anxiety, depression, high levels of expressed emotions etc. (Hersen et al., 2007; MacMillan et 
al., 1986), an ability to experience resilience (Torgalsbøen, 2011) and get out of challenging 
life-courses is suggested to be important for recovery. Resilience refers to a quality to be able 
to return to a level of homeostasis and can be defined through internal criteria of 
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psychological wellbeing (Fletcher & Sarkar, 2013; Masten, 2001); this quality is suggested to 
be enabled by traits in the person (Masten, 2001). Persons with high degrees of experienced 
resilience, with a schizophrenia diagnosis, returns to a level of psychological homeostasis 
after some time have passed. The degrees of resilient traits to the persons are affected by the 
adversity the persons meet and it is suggested that the resilient traits get affected by the 
environment (Bonanno, 2004). Resilience is suggested to be a concept containing of both 
traits and processes (Sarkar & Fletcher, 2014).  High degrees of resilient traits are suggested 
to be favorable for new situations of adversities (Fletcher & Sarkar, 2013). As resilience is 
conceptualised as processes between the person and the environment (Luthar et al., 2000), and 
processes within the person (Masten, 2001), the product of these relations is suggested to be 
named experienced resilience, enabled by both traits and processes. The third wave of 
resilience made two postulates. “Postulate 1: A source for actuating resilience comes from 
one’s ecosystem. Postulate 2: Resilience is a capacity in every soul” (Richardson, 2002, pp. 
314 - 315). These postulates remind researchers and clinicians about the processes in which 
the individuals take part in (Richardson, 2002), and activate ethical discussions regarding 
dividing participants in to groups of resilient and non-resilient. This thesis has taken these 
considerations in to its form and is investigating these relations. The fourth wave has an 
integrated promise to overturn some long-held assumptions of early work on resilience, 
particularly on the plasticity of adaptive functioning itself. It is suggested that fundamental 
adaptive systems that develop within the individual, once thought to be enduring attributes, 
may be “reprogrammable” to a degree unimagined by the pioneers in resilience (Masten & 
Obradović, 2006). These shifts in the resilience research enable hope and might prosper 
interesting research questions.  
1.2.2 Resilience in schizophrenia 
Torgalsbøen (2012) found that recovered persons with a former schizophrenia diagnosis had 
significantly higher resilience scores and significantly lower symptoms scores than 
participants in remission. Those who had a sustained recovery also reported optimism and 
willpower as being significant factors in their recovery. These results provided insight in to 
the possibility of resilience as a predictor for symptom remission and recovery (Torgalsbøen, 
2012b). Torgalsbøen and Rund found a correlation between traits of optimism, willpower, 
resilience and recovery from schizophrenia (Torgalsbøen & Rund, 2010). These findings 
raised the important question of whether this state of mind was intrinsic to the participant and 
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aided in the improvement from the illness or if it was fostered by the recovery (Torgalsbøen, 
2012b). Another question from these findings is if these individuals had taken part in richer 
resilience processes and therefore enhanced their degree of experienced resilience, or if these 
relations are hence resilience processes within the individual made possible by attributes of 
the person, or both. Hansen and Thomassen (2010) found that perceived degree of resilience 
measured with the the Connor-Davidson Resilience Scale is considerably lower in this group 
of persons with schizophrenia than what has been found in the general population and also 
below what has been found in a group of outpatients suffering from other mental illnesses. 
Scores of hope, measured with the Hertz Hope Index, were found to be slightly below the 
mean in the general population. Self-efficacy scores in the patient group, measured with the 
General Self-Efficacy Scale, were found to be scarcely below the mean in the general 
population (Hansen & Thomassen, 2010). These scales measure internal criteria of perceived 
psychological well-being through different constructs such as perceived good relations, hope 
and self-efficacy. This experienced resilience reflects psychological well-being in 
schizophrenia, as suggested by Andresen and collaborators (Andresen et al., 2003), so adding 
these scales together is suggested to reflect levels of psychological well-being that are 
considered important for persons with a schizophrenia spectrum diagnosis. It is theorized that 
the lowered level of resilience reflects the adversity of psychosis, and that this level would be 
higher in a premorbid state of the illness. It could also be the case that these lowered levels of 
experienced resilience are a quality of personality structures in persons who are prone to 
developing schizophrenia. These relations are not known and have not been investigated 
previously. Because these levels are measured after a period of adversity, it is suggested that 
these levels reflects the processes within the person and the processes with the environment; 
experienced resilience, enabled by the adversity and situation of having a schizophrenia 
diagnosis. 
Resilience traits encompassing different outcomes 
Masten and collaborators have defined resilience as “[a] class of phenomena characterized by 
good outcomes in spite of serious threats to adaption or development” (Masten, 2001, p. 228). 
Another definition of resilience is “[a] dynamic process encompassing positive adaption 
within the context of significant adversity” (Luthar et al., 2000, p. 543). Masten (2001) 
emphasizes characteristics within the person and attributes of the environment to be important 
for the outcome, whereas Luthar (2000) emphasizes the dynamic processes between the 
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individual and the environment as important for the outcome (Luthar et al., 2000; Masten, 
2001). The trait-centered model of resilience emphasizes “mental processes and behavior” 
that adapt to the circumstances they encounter, whereas understanding resilience processes 
recognizes that it is “a capacity that develops over time and in the context of person-
environment interactions” (Connor & Davidson, 2003; Egeland et al., 1993; Sarkar & 
Fletcher, 2014). Luthar further states: “Implicit within this notion are two critical conditions: 
(1) exposure to significant threat or severe adversity; and (2) the achievement of positive 
adaption despite major assaults on the developmental process” (Luthar et al., 2000, p. 543). In 
schizophrenia, both psychosis and being diagnosed with a serious mental illness are defined 
as a threat to the person (Torgalsbøen, 2012a). The stigmatization many patients with the 
diagnosis experience can also be seen as a threat to the person (van Zelst, 2009; Zubin & 
Spring, 1977). Two outcomes of resilience are suggested: either a higher level or an equal 
level of psychological homeostasis (Richardson et al., 1990) as compared to levels before the 
adversity. Positive adaption in schizophrenia is suggested to be shown when the person has 
good self-esteem and he or she might think that the experience of the illness has enabled them 
to be the confident person they have learned to be, or if they have found a sense of self despite 
the illness (Andresen et al., 2003; Torgalsbøen, 2012a; Torgalsbøen & Rund, 2010); this view 
emphasizes internal criteria of psychological well-being. Seery, Holman and Silver (2010) 
found that people with a history of some lifetime adversity reported better mental-health and 
well-being outcomes than people with no such history. It is suggested that exposure to 
moderate adversity can mobilize previously untapped resources which can provide a sense of 
mastery for future (Seery et al., 2010), allowing the person to thrive. This suggestion can be 
transferred to schizophrenia, as managing such a serious mental illness may lead to a 
subjective feeling of mastering hard obstacles. When a more resilient individual with 
schizophrenia meets adversity a positive outcome might be enabled. Masten (2001) noted that 
resilience emerges from ordinary processes, a view that makes the construct of resilience 
more available. Resilience may be altered more easily than if it was an unusual phenomena, 
and it can be assessed through positive psychology emphasizing natural processes within the 
person (Masten, 2001). The presence of adversity or stressors (Sarkar & Fletcher, 2014), 
makes the person able to tap in to his or her resilient traits. Emphasizing that resilience 
emerges from ordinary processes within the person makes the characteristics of the person 
and the interaction of those characteristics with the environment important. The resilient traits 
of the person are accessed in relation to the adversity at hand. Resilient traits are affected by 
the individual’s resources and his or her interaction with the environment, enabling higher or 
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lower levels of experienced resilience. The more or lesser dynamic process of resilience 
enabled by both the environment and the person may affect the resilient traits (Bonanno, 
2012), which is theorized to foster higher or lower levels of experienced resilience for the 
individual. 
The positive outcome 
“Individuals are not considered resilient if there has never been a significant threat to their 
development (…) this status or condition is statistically associated with higher probability of a 
«bad» outcome in the future”(Masten, 2001, p. 228). Schizophrenia is associated with a “bad” 
outcome in the short term for many patients, even though longitudinal research shows a more 
positive outcome. As cited in Hersen and collaborators (2007), several studies have shown 
that between 20% to 25 % of patients diagnosed with schizophrenia become fully recovered 
(Hersen et al., 2007). As cited in Larsen and Buss (2008), studies on happiness conclude that 
success in different areas in life is correlated with happiness (Larsen & Buss, 2008). Because 
full recovery in schizophrenia includes social and professional functioning (Torgalsbøen, 
Mohn, & Rishovd Rund, 2014), absence of full recovery is associated with a bad outcome 
when it comes to life satisfaction: “The second judgment involved in an inference about 
resilience is the criteria by which the quality of adaption or developmental outcome is 
assessed or evaluated as ‘good’ or ‘OK’” (Masten, 2001, p. 228). Recovery is normally 
characterized by a temporary period of psychopathology followed by a temporary period of 
healthy levels of functioning, whereas resilience refers to the ability of individuals to maintain 
normal levels of functioning (Bonanno, 2004). Symptom remission is characterized by 
absence of symptoms or minimum levels of symptoms in schizophrenia (Kay et al., 1987). 
“Normal levels of functioning” can either be defined as internal criteria of well-being, as 
external criteria of functioning or both, and is often defined relative to the culture (Masten, 
2001). An illustration of the distinction between resilience and recovery is that bereaved 
persons who demonstrate the recovery pattern may exhibit symptoms of depression and 
having difficulties completing normal daily tasks over a one to two-year period (Mancini & 
Bonanno, 2009). “In contrast, individuals who exhibit resilience seem to be able to proceed 
with their lives with minimal or no apparent disruptions in their daily functioning (when 
bereaved)” (Fletcher & Sarkar, 2013, p. 16). Here resilience is defined as the role of mental 
processes and behavior in promoting personal assets and protecting an individual from the 
potential negative effects of stressors (Fletcher & Sarkar, 2013). Resilience may be defined 
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through both an absence or minimum of psychopathology and in the presence of academic 
and social achievement. Resilience can be defined as both of these being present; this 
definition emphasizes external criteria. Adaption through internal criteria emphasizes 
psychological well-being or low levels of distress; some researchers emphasize both (Masten, 
2001). In academic studies schizophrenia, resilience is suggested to be defined as a positive 
outcome according to an internal criterion of psychological well-being. Personal 
characteristics such as social competence and self-efficacy are suggested to be important in 
resilience in the field of schizophrenia studies (Torgalsbøen, 2012a). A more resilient person 
diagnosed with schizophrenia can be understood as an individual who returns to his or her 
normal levels of psychological well-being despite a recent onset of the illness. It is how the 
person perceives himself or herself (Sarkar & Fletcher, 2014), and his or her relation to the 
environment and the situation that is important. Different criteria of psychological well-being 
are suggested to be important in resilience: stress-coping (Connor & Davidson, 2003), 
integrated performance under stress (Luthar et al., 2000), positive emotions, self-efficacy, 
spirituality, self-esteem (Fletcher & Sarkar, 2013), hope, social competence (Torgalsbøen, 
2012a), optimism (Torgalsbøen & Rund, 2010) less symptomatology, effective mechanisms 
for avoiding unpleasant feelings when in adversity, avoidance of negative life-situations 
(Torgersen & Waaktaar, 2012).  
What about the processes between the individual and environment? 
Resiliency refers to a good outcome with help of social support when experiencing adversity 
(Borge, 2010). Luthar (2006) emphasizes that strong relations can work as protective factors 
and more resilient persons make better use of these because they perceive these relations as 
good (Luthar, 2006). What characterizes resilient children is not necessarily the capacity 
within the child, but rather the relations the child has to others (Bekkhus, 2012). Transferring 
this to schizophrenia, it is the perceived view of social relations and social competence by the 
individual that is important when emphasizing the traits in the person. A non-resilient person 
can get a lot of support but does not have the impression of this, and consequently does not 
make use of it in the same way if needed. In this understanding, a resilient person has a 
perceived view of support from others; actual support is not always necessary. Nonetheless, if 
a person with schizophrenia finds himself or herself in an environment which is hostile to 
schizophrenia (van Zelst, 2009; Zubin & Spring, 1977), it is harder for the person to make use 
of his or her degree of resilient traits. As cited in Torgalsbøen (2012), one study showed that 
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patients with schizophrenia who were fully recovered and had been in longer 
psychotherapeutic treatment showed a better social functioning than other fully recovered 
patients (Torgalsbøen, 2001, 2012a). This might indicate that more resilient persons wanted to 
attend psychotherapeutic treatment because they viewed this as rewarding, which in turn 
enhanced their social competence.  








Environments with support enable more resilience as there is more opportunity for the person 
to make use of the belief in other relations. A good alliance between the therapist and the 
patient with schizophrenia, for example, is suggested to be important (Hagen, 2011; 
Torgalsbøen, 2012a). Experienced resilience in schizophrenia is therefore defined as the 
interactions between degrees of resilient traits and the resilience processes between the 
individual and the environment. The complex processes of resilience enabled by both the 
resilient traits and the interactions between the environment, the person and therapy, are 
described in Figure 2. If these individuals had not been presented for therapy and been in 
highly hostile environments with stigmatization of schizophrenia present, it is theorized that 
less resilience would have been enabled regardless of high degrees of resilient traits within the 
person. The resilience processes within the person are dependent on meeting resilience 






















Figure 3: A resilient person in a supportive environment 






Different environments with lesser or greater degrees of stigmatization may enable different 
outcomes of experienced resilience. Richer degrees of experienced resilience may be enabled 
in supportive environments as described in Figure 3. 







If persons with schizophrenia are in highly hostile environments with stigmatization of 
schizophrenia present, it is theorized that less experienced resilience would have been enabled 
regardless of high degrees of resilient traits within the person, as described in Figure 4. 
To summarize, the outcome of resilience in schizophrenia is a positive outcome in internal 
criteria of psychological well-being. Either an outcome where the premorbid levels of 
psychological well-being is integrated, or where a higher level of psychological well-being is 
attained. The personality traits of the person are emphasized as processes within the 


























resilience processes between the person and the environment. Supportive environments enable 
more experienced resilience, whereas hostile environments enable less experienced resilience.   
The resilient personality structure in schizophrenia  
Torgersen and Waaktaar summarized different types of resilient personalities found in the 
resilience literature. One resilient personality type, which is often suggested in the psychology 
literature, the “complicated type” exhibits high degrees of neuroticism, extraversion and 
consciousness, traits taken out of the Giant Three (Torgersen & Waaktaar, 2012) in the 
Eysenckian system (Ng, Cooper, & Chandler, 1998). This is a personality structure, which 
can be transferred to schizophrenia, that allows individual to find their way through life 
despite emotional difficulties (Torgersen & Waaktaar, 2012). Resilience can be found in the 
stable Big Five personality dimensions (Torgersen & Waaktaar, 2012): neuroticism, 
extraversion, openness to experience, agreeableness and conscientiousness. Personality traits 
are found to be relative stabile entities and reflect a tendency in the individual (Costa & 
McCrae, 1988). Piedmont summarized the traits and facets in the revised NEO personality 
inventory invented by Costa and McCrae (1992). The facet of positive emotions in the trait of 
extraversion “reflects a tendency to experience positive emotions such as joy, happiness, love 
and excitement. (…)  They are seen as cheerful, high-spirited, joyful, and optimistic” 
(Piedmont, 1998, p. 87). Happiness and life satisfaction are found to be related to neuroticism 
and extraversion in general (Piedmont, 1998) and are found to be related to resilience in 
mental health (Torgersen & Waaktaar, 2012). High levels of neuroticism are correlated with 
mental illness, including schizophrenia, and high levels of extraversion are correlated with 
positive emotions and psychological well-being (Piedmont, 1998). Traits influencing 
perceived social support, hopes for the future and self-efficacy are suggested to be important 
for resilience in schizophrenia (Andresen et al., 2003). The trait of extraversion in the Big 
Five covers similar concepts and is important for resilience in schizophrenia. Traits of 
resilience are found to be reproducible and stable in research (Torgersen & Waaktaar, 2012). 
As cited in Torgalsbøen and Rund (2010), Wolin and Wolin (1993) defined resilience to 
include “several protective attributes, such as insight, independence, relationships, initiative, 
creativity, humour, and morality” (Torgalsbøen & Rund, 2010, p. 80). The authors suggested 
these attributes to be important in schizophrenia. Resilient traits enable a higher possibility for 
individuals to adapt to circumstances that they encounter (Connor & Davidson, 2003; Sarkar 
& Fletcher, 2014).  
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Personality variables are found to fluctuate more in childhood than in adulthood, but even 
though personality is more stabilised in adulthood, it is not impervious to situational and 
environmental influences (McCrae et al., 2000). Resilience in particular is somewhat different 
than other types of personality traits as it contains an adversity, which might inform the 
measures of resilience and even the personality (Bonanno, 2012). In the vast majority of 
studies of personality and resilience in adults, the personality variables were measured after 
the adversity. Given the finding that personality get affected by situations and environments, 
especially when measurements of resilience often are taken months after the adversity 
(Bonanno & Mancini, 2008), it is entirely as plausible that the experience of adversity may 
inform the personality variable rather than the other way around (Bonanno & Diminich, 2013) 
and processes might get measured. The term “resilience processes” describes a capacity that 
develops over time in the context of person-environment interactions (Egeland et al., 1993; 
Sarkar & Fletcher, 2014). The process and situation view, and the fact that most resilience 
research is conducted after the adversity call into question the construct of resilience 
conceptualised as only a trait.  
Resilience strategies 
Fletcher and Sarkar made a distinction between coping and resilience which both can lead to 
handling adversities and accessing social support. Resilience influences how an event is 
appraised whereas coping refers to the strategies employed following the appraisal of a 
stressful event. Resilience provokes a positive response (e.g. positive emotions) to a stressful 
situation, whereas coping strategies may be positive (e.g. encouraging self-dialogue) or 
negative (e.g. substance abuse). Highly resilient persons often also exhibit effective coping 
strategies (Fletcher & Sarkar, 2013). An illustration of a resilience strategy is individuals 
operating in a demanding performance environment on a daily basis who would be deemed to 
exhibit resilience if they evaluated stressors as an opportunity for development and 
consequently received peer recognition for their work. By contrast, if individuals operating in 
a similar environment did not react positively and their work suffered and they then sought 
social support from their colleagues, this would be an example of coping (Fletcher & Sarkar, 
2013). Transferred to schizophrenia, seeking social support in crisis might be an example of 
coping if the demands at hand are not viewed as an opportunity for development. Techniques 
that do not take into account hopes for the future, but rather adjust hopes may be enabled. 
Techniques lowering the levels of symptoms (e.g medication) which lead to improving the 
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illness but does not take in consideration the person’s beliefs and hopes may be enabled. The 
capacity to be proactive in the choice of supportive relations and the perceived view of such 
social support is viewed to be important, as opposed to how often support is searched for. A 
more resilient person with a schizophrenia diagnosis would not easily give up his or her 
beliefs and hopes for the future, and would try to seek help where such views are shared. 
Richardson (2002) and collaborators (1990) developed a resiliency model (Richardson, 2002; 
Richardson et al., 1990) in which resilience starts when a person is in balance physically, 
mentally and spiritually. Disruption from this state occurs if an individual has insufficient 
resources to buffer him or her against stressors, adversities or life events. In time, the 
individual will adjust and begin the reintegration process (Fletcher & Sarkar, 2013). As cited 
in Fletcher and Sarkar, the model of Richardson (2002) and collaborators (1990), suggests 
that the reintegration process leads to one of four outcomes: “resilient reintegration (where 
disruption leads to attainment of additional protective factors and a new, higher level of 
homeostasis); homeostatic reintegration (where disruption leads to people remaining in their 
comfort zones, in an effort to “just get past” the disruption); reintegration with loss (where 
disruption leads to the loss of protective factors and a new, lower level of homeostasis); and 
dysfunctional reintegration (where disruption leads to people resorting to destructive 
behaviors such as substance abuse) (Fletcher & Sarkar, 2013, p. 17). Here, resilience traits 
have been assessed and different outcomes are enabled with varying degrees of resilience. A 
possible reason for why one can find resilient persons who do not overcome their illness can 
be that manifested symptoms (for example a strong belief that one is Jesus) do not fit well 
with recovery from the illness. Resilience may lead to remission from symptoms, but may 
also lead to non-remission if the person has acquired a higher level of homeostasis that does 
not fit well with recovery from the illness. The strategy of coping can be a way of becoming 
symptom-free; the person just makes use of the resources at hand to become symptom-free 
without being proactive in the choice of relations (e.g. not choosing relations where hopes for 
the person’s future are shared). This strategy can lead to symptom reduction and in this way 
get the focus back on the resilience processes. A person with schizophrenia can be in 
symptom remission but have no job or social contacts (Torgalsbøen, 2011); if the person finds 
this situation rewarding he or she can be classified as resilient and experiencing resilience. If 
the person does not find this situation rewarding, the person is not defined as resilient when 
internal criteria are emphasized. In the following section, a process of resilient or homeostatic 
reintegration for schizophrenia is described, where a process of experienced resilience is 
enabled when the highly resilient person meets the adversity of schizophrenia. 
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Experienced resilience enabling a positive outcome in schizophrenia 
The concept of recovery in schizophrenia started gaining importance in the 1980s when 
former clients of mental health published accounts of their recovery from serious mental 
illness. Andresen, Oades and Caputi (2003) reviewed this literature and found a new 
definition of psychological recovery based on their research. Here recovery is described 
through hope and self-determination, leading to a meaningful life and a positive sense of self, 
whether or not mental illness is still present. The researchers reviewed literature on the 
recovery process from schizophrenia and recapitulated five stages in this process. 
Moratorium, which is the first stage, is characterized by denial, confusion, hopelessness, 
identity confusion and self-protective withdrawal. Awareness takes place when the person has 
a first glimmer of hope of a better life, and that recovery is possible. This involves an 
awareness of a possible self, other than the “sick person”: a self that is capable of recovery. 
The third stage, preparation, takes place when the person resolves to start working on 
recovering. This stage involves taking stock of the intact self, and one’s values, strengths and 
weaknesses. It involves learning about mental illness and services available, learning recovery 
skills, becoming involved in groups and connecting with peers. Rebuilding, the fourth stage, 
consists of working to forge a positive identity. This is where the hard work of recovery takes 
place, it involves setting and working towards personally valued goals, and may involve 
reassessing old goals and values. Here the person takes responsibility for managing the illness 
and taking control of one’s life. This stage involves taking risks, suffering setbacks and 
coming back to try again. Growth is the final stage, and can be considered as the outcome of 
the recovery process. The person may not be free of symptoms completely, but knows how to 
manage the illness and to stay well. Here resilience is shown in the face of setbacks, the 
person has faith in his or her ability to pull through and maintain a positive outlook. The 
person has a full and meaningful life, and looks forward to the future. He or she has a positive 
sense of self, feeling that the experience has made them a confident person (Andresen, Oades, 
& Caputi, 2003). The person experiencing schizophrenia has acquired techniques which 
enable him or her to have a conception of self and feelings of psychological well-being 
despite the current situation. The last stage in the model of Andresen and collaborators., 
growth, suggests that resilience is shown in the face of new setbacks (Andresen et al., 2003). 
The person has faith in his or her ability to pull through and maintain a positive outlook. The 
person has a positive sense of self and feels that the experience has might been a part of 
making them the confident person they have become (Torgalsbøen, 2012a). The persons who 
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have published their own accounts of their recovery processes are thought to have a higher 
degree of resilient traits and have been able to take part in richer resilience processes with the 
environment, enabling them to have a higher degree of experienced resilience. 
Processes of resilience affecting the resilient traits of the persons 
Luthar emphasizes the dynamic processes between the person and the environment in the 
conceptualisation of resilience (Luthar et al., 2000). These processes are defined in 
schizophrenia as effects from the interactions between the person with schizophrenia and 
supportive or hostile environments (van Zelst, 2009; Zubin & Spring, 1977). These processes 
are defined in schizophrenia as role functioning, social functioning (Torgalsbøen et al., 2014), 
daily functioning (Hansen & Thomassen, 2010), medication (Malt et al., 2003), contact with 
health care, therapists and received psychoeducation (Torgalsbøen, 2011), a good alliance 
between the therapist and the patient (Hagen, 2011; Torgalsbøen, 2012a), substance abuse 
(Melle & Ringen, 2011), life events (Bonanno, 2012; Torgalsbøen & Rund, 2010), HIV/AIDS 
(Gottesman & Groome, 1997) levels of violence (Hersen et al., 2007) levels of expressed 
emotions in the family and environment (MacMillan et al., 1986), and support from family 
and close relations (Lindvåg & Fjell, 2011). Other relations that can play a part are: shifting 
attitudes and ideologies of the culture, mass media, health services, social welfare services, 
legal services, socio-historical conditions (e.g. patterning of environmental events and 
transitions over the life course), school, education, church groups, neighborhood play area, 
neighbors, peers, gender, age and health (Bronfenbrenner, 1992; Gardiner, Mutter, & 
Kosmitzki, 1998; Hess & Schultz, 2008), sexual orientation, nationality and ethnicity. All 
these processes are hard to control for in a big picture, but as these processes take place in 
time (Egeland et al., 1993; Fletcher & Sarkar, 2013; Gardiner et al., 1998), dynamic processes 
between the individual and the environment may be operationalized as effects of time.  
1.2.3 Experienced resilience in schizophrenia 
Personal characteristics of resilience interact with the adversity of schizophrenia and the 
environment, creating a process of resilience between the environment and the person. 
Psychological well-being is the outcome, as defined through a perceived view of positive 
relations, enhanced self-esteem, self-belief and hopes for the future. This outcome is 
dependent on and gets influenced by type of environment the person with schizophrenia 
meets. The degrees of resilient traits in interaction with the degrees of resilience processes 
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between the environment and the person make resilience possible as a positive outcome of 
psychological well-being (Andresen et al., 2003; Luthar et al., 2000; Masten, 2001). The 
product of these relationships is here suggested to be named experienced resilience, enabled 
both by degree of resilient traits though processes within the persons and degree of resilience 
processes, between the environment and the person. Experienced resilience is suggested to be 
understood as a continuous process which affects and gets affected by traits of the person and 
relations between the person and the environment. 
1.2.4 Resilience, vulnerability and symptom remission. 
Figure 5: The complex relationships between degrees of resilience, vulnerability and symptoms within the 
schizophrenia spectrum. These interactions affect and are affected by the environment in resilience processes. 
 
 
Luthar and collaborators emphasize that resilience is a dynamic process which encompasses 
positive adaptation in a context of significant adversity. (Luthar et al., 2000) Rutter has 
described some of the dynamic in the process of resilience, noting “if circumstances change, 
resilience alters” (Fletcher & Sarkar, 2013, p. 15; Rutter, 1987). Zubin and collaborators 
describe schizophrenia in itself as something changeable and dynamic when introducing 
vulnerability as a continuous trait that is present in persons with schizophrenia (Zubin & 






























intervene between the environment and other attributes of the person. These complex 
coherences can have an impact on the outcome of symptom remission and full recovery from 
schizophrenia. The complex and dynamic interactions and processes within the person and 
between the person and the environment, which leads to symptom remission in schizophrenia 
are described in Figure 5.  
Overcoming the illness of schizophrenia is understood as recovery despite major assaults on 
the developmental process from the threat of the psychosis. Symptom remission is understood 
as having a minimum of negative and positive symptoms (Kay et al., 1987). Resilience 
through a higher level of psychological well-being or a “bounced back” premorbid level of 
psychological homeostasis is viewed as achievement of positive adaptation despite the 
adversity presented by the schizophrenia. Symptom remission and full recovery from 
schizophrenia is not equal to resilience. An evaluation regarding the person’s experience of 
quality of life is necessary when encompassing internal criteria of psychological well-being in 
resilience. As cited in Larsen and Buss (2008), Diener, Lucas & Larsen (2003) have found 
that people’s emotional lives and the judgment of how satisfied they are with their lives are 
highly correlated (Larsen & Buss, 2008). This relation is suggested to be present in patients 
with schizophrenia, even though degree of insight might be lower in this group (McEvoy et 
al., 1989). People who have high degrees of pleasant emotions in their lives tend to judge their 
lives as satisfying, and vice versa. As cited in Larsen and Buss (2008), Lyubomirsky and 
collaborators (2005) found that longitudinal studies provide evidence that happiness is prior to 
many positive outcomes in many areas in life (Larsen & Buss, 2008). Resilience, which is 
somewhat similar to happiness and psychological well-being when defined through internal 
criteria, may work in the same way. Psychological well-being may lead to many positive 
outcomes in different areas of life. As cited in Larsen and Buss (2008), Sandvik, Diener and 
Seidlitz (1993) found that persons who report that they are happy tend to have friends and 
family members who agree that they are (Larsen & Buss, 2008). Even though degree of 
insight is found to be lower in persons with schizophrenia (McEvoy et al., 1989), perceived 
psychological well-being of the person is suggested to be reported likewise by persons around 
the person. A person is suggested to know best his or her degree of psychological well-being 
himself or herself (Larsen & Buss, 2008), as it is the person that experiences the quality of 
life. It is possible to be fully recovered from schizophrenia but to have a “broken” self-esteem 
and not look at the experience from schizophrenia as something that has contributed to life 
experience. A highly resilient person bounces back in self-esteem whereas a less resilient 
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person might suffer from symptoms of depression and lowered self-esteem in the aftermath of 
psychosis and may look at the experience as something that he or she would rather be without. 
The degrees of resilience experienced are enabled by both the processes within the persons 
and by the processes between supportive or hostile environments and the person. 
Figure 6: Resilience traits enabling a positive outcome in psychological well-being, which is suggested to foster 





This thesis emphasizes internal criteria of psychological well-being and perceived social 
support. High levels of these characteristics are present in the person, through experienced 
resilience, despite the difficult situation the person finds him- or herself in. It is theorized that 
these high levels of homeostasis can lead to symptom remission. Persons showing resilience 
are considered as being positively adapted regarding psychological well-being despite 
adversities at hand. A resilient person who experiences schizophrenia might encounter 
situations where their vulnerabilities are affected, but it does not affect the person in the same 
way as in the less resilient person. He or she has acquired techniques that make him or her 
able to either understand the symptoms or manage them in a way where hope is maintained. A 

















environment and does not necessarily need these attributes as such an environment does not 
produce the same amount of stressors which can cause positive or negative symptoms (van 
Zelst, 2009; Zubin & Spring, 1977). The more resilient person views the situation with hope 
and self-belief, whereas the less resilient person does not have this view to the same extent.  
The less resilient person is suggested to be more dependent on good periods of being 
symptom-free to have a positive view on life. The more resilient person is not as affected by 
the current adversity as the person who has low levels of resilience. As earlier noted, Seery, 
Holman, and Silver (2010) recently found that people with a history of some lifetime 
adversity reported outcome of  better mental health and well-being than people with no 
history of adversity (Fletcher & Sarkar, 2013; Seery et al., 2010). Silver’s study might 
indicate that going through a process of adversity is something that can actually contribute 
well to a better life. Positive adaptation is shown when the person has a good self-esteem and 
he or she might think that the experience of the illness has made them a confident person 
(Torgalsbøen, 2012a). Adversity promotes psychological well-being in the more resilient 
person because the person gets to know new sides of him- or herself that he or she would not 
have known without this experience. These sides of the person and the experience of success 
with adversity may bring new perspectives to life and foster psychological well-being. The 
outcome of resilience is obtained when the individual has acquired a process assessing 
degrees of resilient traits relevant to the adversity of schizophrenia and has a positive outcome 
in internal criteria for psychological well-being.  
In sum, it is suggested that the more resilient a person with schizophrenia is, the higher 
probability he or she has for coming into richer resilience processes. The consequence of 
resilient traits and resilience processes are higher or lower degrees of experienced resilience, 
defined through psychological well-being. More resilient persons in richer resilience 
processes with the environment experiences more resilience as a consequence. The quality of 
“bouncing back” of resilience is suggested to be important for handling and minimalizing the 






1.3 Purpose of the present study 
Developing a comprehensive understanding of resilience across the lifespan is important for 
mental health, yet resilience has been vastly understudied compared to disease and 
vulnerability (Campbell-Sills, Cohan, & Stein, 2006). Earlier research has suggested a 
relationship between resilience and remission from schizophrenia (Torgalsbøen, 2012b; 
Torgalsbøen & Rund, 2010). The concept of resilience in schizophrenia is clinically relevant 
because it can have an impact on treatment types that assesses degrees of resilience, which 
can contribute to psychological wellbeing. High levels of psychological well-being are 
associated with life satisfaction (Larsen & Buss, 2008) which users of mental health services 
find important (Andresen et al., 2003). Research on patients with serious mental illnesses 
suggest that a positive outcome in psychological well-being can contribute to symptom 
remission and full recovery for patients with schizophrenia (Andresen et al., 2003). 
Investigation of the predictive value of resilience, defined through psychological well-being. 
has not been systematically researched before in the field of schizophrenia (Hansen & 
Thomassen, 2010). Research analysing the relationship between resilience and symptom 
remission is therefore important, as symptom remission is a measure used to describe 
psychological functioning in mental health (DSMPsychiatryOnline, 2014; Organization, 
1993). Such research can therefore have an impact on the type of treatment given. 
In this thesis we address three research questions: 
1. Is there a relationship between degrees of experienced resilience and symptom 
remission in schizophrenia at 2-year follow-up? 
2. Is experienced resilience in schizophrenia a concept involving both resilient traits and 
resilience processes between the individual and the environment? 






This thesis is part of a larger ongoing research project at the Department of Psychology, 
University of Oslo, with Associate Professor Anne-Kari Torgalsbøen as the principal 
investigator. The research project is a prospective longitudinal study on first-episode 
schizophrenia patients that examines neurocognition and resilience as possible predictors of 
recovery during the early, and late course of the illness. The research project investigates the 
stability and rate of full recovery during a 10-year follow-up, using consensus based 
definitions of remission and full recovery in schizophrenia (Torgalsbøen et al., 2014). Written 
informed consent is obtained, and the recruiting of participants and routines for the gathering 
of data has been approved by the Regional Committee for Medical Research Ethics in Region 
South (REK). 
2.1 Subjects 
Over a period of four years (2007-2011) 28 patients with first-episode schizophrenia were 
referred to the study. They were recruited from Vestre Viken Health Trust and Lovisenberg 
Diakonale Hospital. All participants could read and write Norwegian fluently and were of the 
ages of 18 years and upwards. The participants were diagnosed using the Structural Clinical 
Interview for DSM-IV (SCID) (American Psychiatric Assoaciation, 1994) by their referring 
therapists; all participants had a diagnosis within the schizophrenia spectrum at inclusion. 
Criteria for exclusion were affective disorder, IQ below 70 and brain damage. The control 
group consisted of healthy controls that were matched pairwise with the patient-group on 
important demographic variables such as gender, age and partly on education.  
At 2-year follow-up, three subjects had dropped out of the study. Due to the nature of 
statistical analysis, only subjects who were assessed at all follow-up points (baseline, six- 
month, one- and two-year) are included in this thesis. This leaves 25 participants for the final 







Table 1:  Demographic and clinical characteristics for the participants (N=25) 
 Mean SD Range 
Age 21.1 2.6 18-27 
Years of education 13.0 1.9 10-18 
Months of untreated psychosis 16.1 16.2 1-60 
  Frequency Percent 
Gender Female  11 44.0 
 Male  14 56.0 
Level of education Secondary school  9 36.0 
 Upper comprehensive school  9 36.0 
 Started higher education  6 24.0 
 Bachelor degree  0 0.0 
 Master degree  1 4.0 
Type of diagnosis Schizophrenia  17 68.0 
 Schizoaffective disorder  6 24.0 
 Psychosis – unspecified type   2 8.0 
Treatment status Hospitalized  16 64.0 
 Outpatient  9 36.0 
Antipsychotic medication Baseline  24/24 100.0 
 6-month follow-up  22/23 95.7 
 1-year follow-up  18/18 100.0 








2.2 Clinical instruments 
The clinical interviews and tests of the participants were done within the first five months of 
their admission to hospital or out-patient clinic, and were carried out by an experienced 
clinical psychologist. Diagnoses were established using the Structural Clinical Instrument of 
Diagnosis for DSM-IV Axis I disorders (SCID-I), modules A-D. The degrees of 
psychopathology were measured with The Positive and Negative Syndrome Scale (PANSS) 
(Kay et al., 1987; Torgalsbøen et al., 2014). 
2.2.1 Resilience assessment 
To assess resilience, the Connor-Davidson Resilience Scale (CD-RISC) (Connor & Davidson, 
2003) is chosen. The CD-RISC is a 25-item scale that measures underlying traits in the person 
(Connor & Davidson, 2003) and is often used to measure resilience.  This scale is translated 
into Norwegian and has demonstrated sound psychometric properties and distinguishes 
between persons with greater and lesser resilience. The scale comprises 25 items, each rated 
on a 5-point scale (0 – 4) with higher scores reflecting greater resilience. In addition, the 
Generalized Self-Efficacy Scale (GSE) (Schwarzer & Jerusalem, 1995) and the Herth Hope 
Index (HHI) (Herth, 1992) are used. The GSE is based on Bandura’s conceptualisation of 
self-efficacy, and assesses self-perceptions regarding one’s ability to successfully perform a 
behavior, and reflects an optimistic self-belief (Schwarzer & Jerusalem, 1995). Expectancies 
of self-efficacy have been shown to exert influence on the ability to initiate and persist in 
behavior. This scale is translated into Norwegian, showing high reliability. The scale consists 
of 10 items rated on a 4-point Likert scale. The Herth Hope Index is translated into 
Norwegian and measures the level of general hopefulness of adults in clinical settings. The 
scale consists of 12 items, each rated on a 4-point Likert scale that ranges from strongly agree 
to strongly disagree. The measures of resilience traits are operationalized in this thesis by 
adding these scores together based on the theory that resilience contains the constructs 
underlying these scales. 
How to measure the underlying resilience construct 
Connor and collaborators (2003) found that their resilience scale could be modified by 
treatment in mental illness such as General Anxiety Disorder (GAD) (Connor & Davidson, 
2003). It is theorized that situations and other mental illnesses can also affect resilience 
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measures. Patients diagnosed within the schizophrenia spectrum often develop anxiety and 
depression in the short term (Hersen et al., 2007), which may affect the resilience scores at 
each time point. The person might be depressed, have high levels of anxiety, have high levels 
of positive and/or negative symptoms within the schizophrenia spectrum or be in a situation 
which is theorized to be able to affect the resilience measure. More resilient persons with 
schizophrenia proceed through this adversity with somewhat intact levels of psychological 
well-being. This happens despite the current situation and the experience with the illness after 
a short time; in this thesis, this time is operationalized to be over one year. The participants 
can experience less resilience at certain test points, but can, over a longer time-period, show 
high resilience despite the given situation at each test point. Aggregation is to measure the 
average over many situations. The person-situation debate concluded that aggregation is the 
best measure of personality as “behavior can be situationally specific at the item level and 
cross-situationally general at the aggregate level” (Epstein & O'Brien, 1985, p. 513). In other 
words, measuring at one occasion gives a better understanding of the situation the person 
finds himself or herself in at the time of assessment and does not necessarily assess the 
underlying personality traits. By aggregating, phenomena such as depression and anxiety are 
taken into account. Aggregation measures the resilience traits better, and the scores are less 
affected by the person’s situation at the time of measurement. However, the processes the 
individuals find themselves in are thought to affect the scores as the scores may shift from 
situation to situation. Experienced resilience is defined as a combination of processes and 
traits; because these relations are hard to investigate, the measures for personality are used in 
resilience research (Bonanno, 2012). Because resilience is assessed after the adversity, it is 
difficult to conclude if resilience should be conceptualised as either a trait or a process 
(Bonanno, 2012). Aggregation takes away the focus away from the situation, and it is 
therefore theorized that the focus is more on processes and traits. Processes happen in time 
and are the effect of interactions between a person and his or her environment; they are 
therefore operationalized as effects of time on the scores. The stability and coherence of traits 
and processes are suggested to be found through correlating different assessment points of 
resilience. 
As presented in the introduction, resilience is defined in this thesis as including psychological 
constructs of perceived hope for the future, perceived self-efficacy and perceived social 
support. The items in HHI, GSE and CD-RISC measure similar constructs and are used to 
measure resilience in this thesis. Questions concerned with hope regarding the future, faith, 
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and self-efficacy and questions concerned with perceived view of social support are 
emphasized using these scales. Luthar (2000) emphasizes relations as important in resilience 
and this aspect is taken into account by the scales (Luthar et al., 2000). The HHI has 
individual items for feelings of being alone and of being able to give and receive care or love 
(Rustøen et al., 2003). The CD-RISC has individual items regarding close and secure 
relationships and knowing where to turn for help (Connor & Davidson, 2003). The other 
items in the scales mostly cover other internal criteria such as perceived view of adapting to 
change, pride, faith, coping with stress and the handling of unpleasant feelings, as well as 
being able to recall pleasant times, having inner strength and a positive outlook towards life. 
The items also assess one’s belief in their ability to respond to novel or difficult situations and 
to deal with any obstacles or setbacks (Connor & Davidson, 2003; Leganger, Kraft, & 
Røysamb, 2000; Rustøen et al., 2003). In sum, different items regarding psychological well-
being are measured, emphasizing a positive outcome in internal criteria.   
Twenty-five participants were tested at all four time-points, while three participants did not 
fill out the measures for CD-RISC at baseline. The average of the baseline assessment was 
found to be as follows: HHI had scores between 12 and 48, GSE had scores between 10 and 
40 and the CD-RISC scale had scores between zero and 100. As the different indices contain 
scores ranging on diverse scales; therefore the scales were put in the same form by assessing 
standard deviation scores instead. This was done by setting the scores of the three different 
scales in z-scores using the computer program Predictive Analytics Software Statistic 18 for 
Windows (PASW). The scores at each test point were added together and divided by three to 
find the resilience scores for each test point. Because resilience is suggested to be 
conceptualised best through aggregation, the scales were aggregated over the first three time 
points. To find this score, the three new scores containing CD-RISC-, HHI- and GSE scores 
for baseline, 6-month and 1-year assessment were added together and divided by three. CD-
RISC has good internal consistency, with a Cronbach alfa coefficient reported of 0.89 
(n=577), for the full scale (Connor & Davidson, 2003). The other scales are also found to 
have good internal consistency with high Cronbach alpha coefficients (Herth, 1992; Leganger 
et al., 2000; Schwarzer & Jerusalem, 1995; Wahl, Rustøen, Lerdal, Hanestad, & Moum, 2004) 
It is theorized that these scales and the constructs measured hold their grade of validity when 




2.2.2 Definition of symptom remission 
The symptom remission criteria for schizophrenia were taken from published criteria 
(Andresen et al., 2003) and are assessed using The Positive and Negative Symptoms Scale 
(PANSS) (Kay et al., 1987). The criteria for symptom remission is based on an evaluation of 
eight groups of symptoms: delusions, unusual thought content, hallucinatory behavior, 
conceptual disorganisation, mannerisms and posturing, blunted affect, social and emotional 
withdrawal, and lack of spontaneity. The score of these items must be mild or less than three 
(< 3), using the 1–7 range of each item with a duration of six months as a minimum threshold 
(Kay et al., 1987). The dependent variable of symptom remission is categorical, dividing the 
participants into two groups of “in remission” and “non-remission.” PANSS has a good 
internal consistency, with a Cronbach alpha coefficient reported of .79 for the full scale 
(N=101) (Kay et al., 1987).  
2.3 Design and data analyses 






The aim of this study is to uncover tendencies in a small sample. All statistical analyses were 
performed using the computer program Predictive Analytics Software Statistic 18 for 
Windows (PASW). Descriptive analyses were performed to map the distribution of data for 
resilience and symptom remission and to check for tendencies. As resilience is a continuous 
variable, an outlier analysis was conducted. Data from baseline assessments (T1), 6-month 
assessments (T2), 1-year follow-up (T3) and 2-year follow-up (T4) were measured for 
symptom remission and resilience. Scales for resilience are aggregated for the first year, and 
symptom remission is obtained with six months of minimum symptoms (< 3) and is assessed 
at the second year in the predicting analyses. A reliability test for aggregated resilience was 
Resilience 





performed, putting each of the scales on the three test-points together in a reliability analysis. 
The Cronbach alpha coefficient had a high value of .82 (N = 25). A factor analysis to check 
for different factors measured by the new scale was not conducted as the N was too low. If a 
factor analysis had been conducted, the new scale containing all three scales might have 
contained more or fewer factors than the original scales. The constructs behind each of the 
scales may overlap, which could result in different factors from a factor analysis. It is the 
questions asked in the measures that are relevant, rather than the individual factors and 
whether these overlap. It is theorized that the resulting underlying construct of resilience, 
defined through internal criteria of psychological wellbeing, is measured better when mixed in 
this way. The design of the study is described in Figure 7. 
The strength and direction of the relationship between aggregated resilience for the first year 
and symptom remission at 2-year follow-up was assessed by the Pearson’s product-moment 
correlational analysis. As suggested in Pallant (2007), the outcome was interpreted by using 
guidelines suggested by Cohen (1988) (Pallant, 2007). The amount of shared variance (r
2)
 is 
found from these calculations. This value represents the proportion of variance in the outcome 
variable that is explained, or shared, by the independent variable. Further correlations were 
performed to control for other associations influencing the relationship between resilience 
measures and measures of symptom remission. To deepen into the construct of resilience, 
further correlation analyses were done to investigate resilience conceptualised as traits, 
processes or both. Because the variables were categorical and continuous correlational 
analyses were conducted to investigate for tendencies and associations between different 
assessments (Howitt & Cramer, 2008; Pallant, 2007). To investigate the predictive value of 
degrees of resilience on symptom remission, logistic regression was used. This choice was 
made because the outcome variable for symptom remission is categorical (Howitt & Cramer, 
2008; Pallant, 2007). Because of ethical considerations regarding a division between resilient 
and non-resilient persons, resilience is here used as a continuous variable. Further logistic 
regressions were conducted to control for effects of other variables, including gender, age, 
years of education and PANSS scores at baseline. These were conducted to investigate for 
tendencies and to see if these variables affect the relationship between resilience and symptom 
remission. As the categorical variable of symptom remission is originally a continuous 
variable, ANOVA could have been used (Howitt & Cramer, 2008; Pallant, 2007). However, 
since research and clinical practice use the division of remission and non-remission 





Figure 8: Mean scores for resilience at each test-point (N = 25)  
 
Descriptive analysis for the resilience scores at each test-point was performed. Figure 8 shows 
the mean scores for the group at each test point for resilience. Figure 13 in the appendix 
shows aggregated resilience scores for the first year measured in standard deviation for the 
participants applied in six different groups with varying levels of resilience. Most participants 
are situated around the central tendency, with a mean of -.06. A skewness number of .31 
indicates that there is a lack of symmetry around the central tendency. This is caused by the 
fact that many participants show either a higher degree of resilience or that they are situated 
around the central tendency (e.g. scarcely over or under the mean). As many participants are 
situated scarcely below the mean, it is theorized that if another group of patients had taken 
part in the study, the mean would have been different and some of the less resilient persons 
would have been categorized as highly resilient, or vice versa. A kurtosis number of .04 
reflects a steep curve which indicates that there are differences between the different 
resilience groups. 
Statistical analyses were applied to assess the normality of the variables as many statistical 
techniques are sensitive to outliers. As illustrated by Figure 14 in the appendix, the normal Q–
Q plot shows a reasonably straight line with no clustering of points, with most points 
collecting around the zero-line. This suggests a normal distribution of resilience scores within 
the patient group, which is also indicated by the normal shape in Figure 8. The Kolmogorov– 
Smirnow test of normality also indicates a normal distribution of resilience scores (p = .20) 











mean; one participant had a value of 1.13, the second participant had a value of 1.17 and the 
third participant had a negative value of -1.25. All these participants were more than one 
standard deviation over or below the normal; therefore an outlier analysis was conducted. The 
original mean and the new, trimmed mean are compared. As seen in Table 4 in the appendix 
section, the more extreme scores have insignificant influence on the mean and are therefore 
retained in the data file. 
3.1.2 Symptom remission 
Figure 9: Participants in remission at each test-point (N = 25) 
 
At baseline one person was in symptom remission of the 25 participants included in the 
analyses. There was an increase of participants in remission from baseline to 6-month follow-
up, with 16 persons in remission. At the 1-year follow-up, 22 persons were in remission and at 
the 2-year follow-up 20 participants were in remission which is a little decrease from the 1-
year follow-up. A skewness number of -1.60, found from descriptive analysis, shows that 
there is a lack of symmetry around the central tendency at 2-year follow-up. This is caused by 
the fact that most participants (n = 20) are in symptom remission at this point. A kurtosis 
number of .59 reflects a steep curve which indicates that there is a clear difference between 
the two groups; 80% of the participants are in symptom remission. Symptom remission is a 
variable that is not expected to be normally distributed, so a Q-Q plot or an outlier analysis 
was not performed. The amount of participants in symptom remission at each test-point is 













3.1.3 The strength and direction of the relationships. 
The relationship between aggregated resilience over the first year and being in symptom 
remission at 2-year follow-up was investigated using the Pearson product-moment correlation 
coefficient. As shown in Table 2, there is a positive and medium-strong correlation between 
these two variables (r = .44, p = < .05). High levels of resilience are associated with symptom 
remission at the second year. Shared variance is 19.45 % which represents the proportion of 
variance in symptom remission that is shared or explained by resilience.  
Correlation analyses to investigate the relationships between symptom remissions at different 
test-points were performed to check for coherences. Symptom remission at six months follow 
up and 1-year follow-up are associated with symptom remission at 2-year follow-up ( r =  
[.43, .46], p < .05). To investigate for new associations between resilience and symptom 
remission, relationships between resilience at different time points and symptom remission at 
different time-points were analysed. These analyses found that resilience measured at 1-year 
follow-up is associated with symptom remission at 2-year follow-up (r = .41, p < .05), 
whereas the other relationships between assessments of symptom remission were not 
statistically significant (p > .05). When symptom remission measured at earlier time points 
was correlated with resilience measures at later stages, no significant results were found (p > 
.05). To investigate for associations between resilience measured at different time points, and 
single assessment resilience compared to aggregated resilience over one year, new analyses 
were conducted. All individual resilience measures were found to be strongly correlated to 
aggregated resilience over one year (r = [.61, .82, .82], p < .01). To investigate the 
relationships between single assessments of resilience and predictive ability of aggregate 
resilience, the resilience score of T4 was included in the correlations. The construct of 
resilience is still operationalized to take place during the first year, but other effects are 
controlled for here. The relationships between single assessments of resilience were found to 
be either strongly correlated when time passes (r = [.61, .58], p < .01), or non-significant and 
small to medium correlated after intake (r = [.19, .22], p > .05). The relationship between 
aggregated resilience over one year was found to be statistically significant and strongly 
correlated to resilience measured at 2-year follow-up (r = .52, p > .05). The correlations are 





Table 2: Pearson Product-Moment Correlation between resilience and symptom remission (N = 25) 
Scale 1. SR T4 
2. R 
T1toT3 3. SR T1 4. SR T2 5. SR T3 6. R T1 7. R T2 8. R T3 9. R T4 
1. Symptom  
remission at T4 -         
2. Resilience 
measured over one 
year .44* -        
3. Symptom  
remission at T1 . . -       
4. Symptom  
remission at T2 .46* .36 . -      
5. Symptom  
remission at T3 .43*. .24. .  .24 -     
6. Resilience 
measured at T1 .20 .61** . .14 .27 -    
7. Resilience 
measured at T2 .37 .82** . .42* .17 .22 -   
8. Resilience 
measured at T3 .41* .82** . .26 ..11 .19 .61** -  
Resilience measured 
at T4 .49* .52** . .29 .04 .24 .35 .58** - 
Note * p < .05 ** p < .01 SR is an abbreviation for Symptom Remission, R is an abbreviation for Resilience 














3.1.4 The impact of experienced resilience on symptom remission. 
In order to assess the impact of resilience on symptom remission at 2-year follow-up, direct 
logistic regression was performed. The model contained two variables: resilience and 
symptom remission. The full model was statistically significant ӽ2 (2, N = 25) = 5.913 (p = 
.015), indicating that the model was able to distinguish between respondents who were in 
symptom remission and those who were not. The model as a whole explained between 21.1% 
(Cox & Snell R Square) and 33.3% (Nagelkerke R Square) of the variance in remission at 2-
year follow-up and correctly classified 84.0% of the cases. As shown in Table 3, the 
independent variable of resilience made a unique statistically significant contribution to the 
model (p < .05). Resilience predicts symptom remission with an odds ratio of 13.28. 
In order to control for the possible influences of other variables and to check for tendencies in 
the group, further direct logistic regressions with symptom remission as the dependent 
variable, including different predicting variables were performed. Different models with 
variables from baseline assessment, including gender, age, years of education and PANSS 
score, were performed to control for the effects these measures have on resilience. A direct 
logistic regression with variables of resilience, gender, age and years of education was 
performed; this model had no statistically significant variables. To control for effects of each 
of the variables separately, new analyses controlling for each of these three variables and the 
variable of PANSS score, in four different models were performed. These full models were 
found to be statistically significant and the degrees of explained variance were increased, with 
all models finding high odds ratios for resilience and most models finding this predictor to be 
statistically significant (p < .05). Even though it is found high odds ratios, it is also found big 
confidence intervals that give somewhat unsure estimates ranging in the intervals. When 
resilience was investigated without controlling for other variables, it was a statistical 
probability of 95% that the right odds ratio was between 1.04 and 169.46, which are 
somewhat other numbers than the original 13.28. This is found to be a tendency when 
controlling for other variables to. To control for tendencies, several new logistic regressions, 
which are not described further here, were conducted to control for effects from other 
variables. Variables of neurocognitive functioning, social functioning, role functioning, 
medication, type of schizophrenia diagnosis, type of education, and other variables were 
controlled for. These analyses showed a trend towards a predictive value for resilience, with 
statistically significant and non-statistically significant values for resilience. In Table 3, the 
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exact statistical significance levels for the main analyses are shown to give a clearer picture of 
this relation. 






























21.1 –   
33.3 % 
84.0 % Resilience 
2.59 1.30 3.96 1 .046 13.28 1.04 169.46 
Resilience – 
Gender Age  
Years of 
education 
51.5 –   
81.4 % 
92.0 % 
Resilience 5.99 5.44 1.21 1 .271 397.75 .01 16948090.37 
Gender 
-
23.23 9435.25 .00 1 .998 .00 .00 . 
Age .04 .87 .00 1 .967 1.04 .19 5.68 
Years of 
education .62 1.52 .17 1 .684 1.86 .09 36.81 
Resilience – 
Gender 
50.8 –   
80.3 % 
92.0 % 
Resilience 8.55 5.39 2.52 1 .113 5180.69 .13 201749076.3 
Gender 
-
26.48 8758.03 .00 1 .998 .00 .00 . 
Resilience – 
Age 
21.4 –   
33.9 % 
80.0 % 
Resilience 2.62 1.30 4.05 1 .044 13.73 1.07 175.83 







Resilience 3.03 1.48 4.17 1 .041 20.62 1.13 376.37 
Years of 





34.4 –   
54.3 % 
80.0 % 
Resilience 4.69 2.27 4.28 1 .039 109.08 1.28 9298.94 
Total 
PANSS 
score .09 .05 2.80 1 .094 1.09 .99 1.21 
Note Explained variance represents the Cox & Snell R Square and the Nagelkerke R Square values, which 









4.1 Resilience and symptom remission in 
schizophrenia. 
Data from this study investigates the relationship between resilience and symptom remission, 
if experienced resilience is a result of traits and processes, and if experienced resilience is 
predictive for symptom remission in schizophrenia. As presented in the introduction, previous 
studies have investigated whether resilience is correlated with recovery in schizophrenia 
(Torgalsbøen, 2012b; Torgalsbøen & Rund, 2010). Hansen and Thomassen (2010) found that  
degree of perceived resilience measured with the CD-RISC, degree of hope measured with the 
HHI and self-efficacy measured with the GSE in the patient group were below the mean in the 
general population (Hansen & Thomassen, 2010). The aggregated resilience for the three 
constructs in one has not been correlated with other groups in this thesis, but it is theorized 
that the normal population would have higher experienced resilience scores compared to this 
patient group if measured on these scales. The aim in this thesis is to measure degree of 
experienced resilience and whether this degree is predictive for symptom remission, not to 
find out who is resilient compared to a control sample. As the persons in this study would 
have been part of the general population before the onset of the schizophrenia diagnosis, it is 
theorized that the participants had higher degrees of resilience before the adversity of 
schizophrenia. The predictive value of experienced resilience and in-depth analyses of the 
resilience construct in schizophrenia is not known to have been investigated before. 
4.1.1 Is there a relationship between degrees of experienced 
resilience and symptom remission in schizophrenia at 2-year follow 
up? 
The relationship between resilience and symptom remission at 2-year follow-up is found to be 
moderately strong with a positive direction. The more resilience experienced by a person the 
higher is the probability that the person will be in symptom remission at 2-year follow-up. If 
in symptom remission at 2-year follow-up, the higher the probability is that the person had 
high degrees of experienced resilience over the first year. At 2-year follow-up 80% of the 
participants are in symptom remission and the participants are showing the highest degrees of 
resilience at this point. Single assessment of resilience is found to be moderately correlated 
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with symptom remission at 6-month follow-up and at 2-year follow-up on a statistically 
significant level. Resilience measured at 1-year follow-up is moderately correlated with 
symptom remission at 2-year follow-up. The other correlations between single assessment 
scores of resilience and symptom remission are not statistically significant. These results 
indicate that symptom remission is not always predicted by resilience when assessed at one 
point in time. The aggregated score of resilience over 1 year is found on these results to be a 
better predictor for symptom remission than just assessed at one occasion. When time passes, 
the number of participants in symptom remission increases, and this may influence the 
resilience scores at each time point. The resilience scores might be affected by being in 
symptom remission as well, although it is not necessarily clear in which direction. To control 
for this relation, symptom remission was correlated prior to single assessment of resilience at 
later stages, which indicated that symptom remission does not predict more resilience, hence 
the fact that these relations were not statistically significant. High degrees of resilience over 
one year foster symptom remission later on, whereas a result supporting the opposite direction 
is not found. As shown in Table 3 in the results section, there were found moderately strong 
relationships between symptom remissions measured at 6-months follow-up and 1-year 
follow-up compared to symptom remission at 2-year follow-up. The other correlations 
between symptom remissions were not found to be statistically significant. These results 
indicate that if a person is in symptom remission between the six-month and one-year 
assessments, there is a statistical probability that the person will be in symptom remission at 
2-year follow-up. In other words, to be in symptom remission is a predictor for sustained 
symptom remission, when time passes. These results indicate that resilience is a predictor for 
symptom remission, which increases the probability for sustained symptom remission. The 
results support the relevance of resilience as predictive for symptom remission and may 
indicate that experienced resilience is a more latent factor, manifested as traits or a stable 
process, since symptom remission is not found to predict resilience. These results support and 
are in accordance with earlier research which has found that the individual’s subjective view 
of health is a more important predictor of hope than the presence of chronic disease itself 
(Rustøen et al., 2003). As seen in Table 1 in the method section, most participants are on 
medication during this period. Medication is found to reduce symptoms of psychosis (Malt et 
al., 2003) and is thought to let the individuals focus on other things than their symptoms 
(Oppjordsmoen, 2011). It has also been found, however, that sustained use of medication is 
not necessary for recovery (Torgalsbøen & Rund, 2010). These relations may have an impact 
on the increasing graph of patients in symptom remission from intake to 6-month follow-up. 
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Medication is therefore suggested to reduce symptoms in an early stage in the illness, whereas 
use of medication is suggested to be able to be reduced when the person is in symptom 
remission. The person might not need medication later to be in symptom remission. As most 
of the patients are on medication throughout this period of two years, the use of medication 
which contributes to symptom reduction is suggested to not affect the relationship between 
experienced resilience and symptom remission, as medication is thought to not enter degree of 
underlying resilience. 
These findings support the research question that degrees of experienced resilience are 
associated with symptom remission in schizophrenia at 2-year follow-up. It is also suggested 
on the basis of these results that symptom remission is not predictive for higher resilience 
scores; this relation is not explored any further. 
4.1.2 Is experienced resilience in schizophrenia a concept involving 
both resilient traits and resilience processes between the individual 
and the environment? 
To investigate whether resilience is best conceptualised as traits, processes or both, 
correlational analyses of resilience measured at different time-points were conducted. Single 
assessments were also compared to aggregate resilience, over one year. These analyses 
showed only strong positive relationships, indicating that if a participant shows resilience at 
one point there is a statistically high probability that the person will show resilience over a 
period of time. The relationships between baseline assessment and later assessments of 
resilience were found to be non-significant and weak to medium strong, indicating that the 
resilience traits are not stabilised during the first six months, and are more influenced by 
interaction with the environment. The decreasing graph of the resilience scores from baseline 
to 6-month follow-up represents a lowered level of psychological well-being for the whole 
group. As this correlation was not statistically significant, it is not a reliable predictor of how 
persons will score in this period. After 6-month follow-up the graph increases up to 1-year 
follow-up and to 2-year follow-up. The analyses showed strong positive correlations between 
6-month follow-up and one 1-year follow-up, and between one 1-year follow-up and 2-year 
follow-up. These results and the increasing graph, represented in Figure 8 in the results 
section, indicate that the persons are “bouncing back” in psychological well-being and that 
this process has been stabilised, hence predictive values are found in this time-period. 
Resilience measured over one year was also found to be predictive for resilience measured at 
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2-year follow-up, as this relationship was found to be statistically significant. Resilience 
measured at one occasion is not found to be stably predictive for single-assessment of 
resilience later on, established through statistically significant and non-statistically significant 
correlations. These findings are in concordance with the theory that to aggregate is a better 
construct for personality than to only measure at one occasion (Epstein & O'Brien, 1985), and 
that resilience measured over one year is predictive for degrees of resilience at a later stage. 
The results indicate that to predict degree of resilience from situation to situation in the first 
six months in not trustworthy. Predicting resilience from situation to situation is more 
trustworthy after six months as the resilience construct has stabilised more and strong 
correlations are found. Stabilisation occurs when most participants develop symptom 
remission in the first six months. This suggests effects from the processes between the person 
and the environment play a role in experienced resilience when in non-remission, but does not 
play such a big part when in remission. Since single assessments of resilience are strongly 
correlated with aggregate resilience, measuring resilience at one occasion gives an indication 
of levels of experienced resilience by the individual, which gives an estimate of degrees of 
resilient traits of the person. 
The interactions with the environment in which participants take part in the early stages of the 
illness are found to be important for later levels of experienced resilience. As this group of 
patients has been in untreated psychosis for 13.3 months, including the 3 dropouts 
(Torgalsbøen et al., 2014), the kind of support and treatment given and whether or not good 
relationships were established when taken in to health-care is suggested to be important for 
the outcome regarding stabilisation of resilience. It is theorized that resilience traits are not 
stabilised when psychosis is untreated, but this hypothesis has not been tested. Research 
investigating persons who are not taking part in hope-enabling processes, to see how they 
cope, introduce an ethical consideration. To not communicate knowledge of the possibility for 
a valuable life and recovery when this is known to prosper improvement is an ethically 
difficult act, and should therefore be considered carefully if ever done. An implication from 
this is suggested to be that the adversity of having positive and negative symptoms affects the 
stability of traits, which can indicate a quality of non-remission in schizophrenia. Since no 
statistically significant results were found between longer intervals of single resilience 
assessments, it is suggested that the traits are not fully stabilised and that the persons are 
affected by interactions with the environment. The graph in Figure 8 in the results section 
reflecting levels of psychological well-being is suggested to reflect the quality of resilience of 
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“bouncing back”, but it might also be the case that this trend is due to chance. The graph 
could reflect part of a continuous increasing and decreasing graph, if investigated over a 
longer time-period, rather than a graph that is found to be stabilising and increasing after 
some time. This continuous stability/instability quality or the increasing/decreasing quality on 
longer time-intervals have not been investigated in the lack of data for such analyses. Because 
earlier research has found that the ability to bounce back is the quality of resilience, and 
increasing and decreasing of the graph at later stages can reflect other adversities, it is 
suggested that the quality of resilience is reflected in the graph in Figure 8. Regardless, single 
time-points of the graph may give another picture if deepened in to, and the ability to bounce 
back is suggested to be an ongoing process within the person in interactions with processes of 
the environment.  
In total, these results indicate that it is difficult to predict degree of resilience from situation to 
situation in the six first months, but the scores become more predictive as time passes. These 
results indicate that measuring resilience over a period of time is a good operationalization of 
the resilience construct; the traits get a chance to stabilise. Since all single assessments of 
resilience are strongly correlated to aggregated resilience, and resilience measured over the 
first year is correlated with resilience at 2-year follow-up, measuring resilience at one 
occasion is suggested to show some predictive value for later improvement. This implicates 
that there is a predictive value of scores done at baseline, but this predictive value is not a 
good predictor for later scores. Processes of resilience are suggested to be more important 
when the participants are in psychosis, with more unstable resilience traits which are 
suggested to be more vulnerable to environmental factors. The importance of the environment 
declines over time, but does not disappear; therefore experienced resilience is suggested to be 
a result of both traits and processes between the individual and the environment. 
Traits and processes enabling a positive outcome 
Rutter (1987) emphasized that traits of resilience differ on how they score; the traits are 
themselves in a process, which reflects the quality of resilience of “bouncing back” to 
psychological well-being (Borge, 2007; Fletcher & Sarkar, 2013; Rutter, 1987). This quality 
is suggested to make persons vulnerable to factors in the environment in which they find 
themselves. The participants are theorized to have had measures around the same level as the 
normal population before the adversity, as the levels of these different scales are measured to 
be a bit lower than the normal population (Hansen & Thomassen, 2010). It might also be the 
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case that, in a premorbid state, these levels would be measured as lower than the normal 
population, as low levels of experienced resilience might be a part of the predictability of 
acquiring a schizophrenia diagnosis, and might be part of the illness. As most research into 
resilience measures resilience after the adversity, it is hard to conclude if the levels of 
psychological well-being actually “bounce back” to a premorbid level of psychological well-
being and to conclude that it is only traits that are measured (Bonanno, 2012). Some of these 
effects are taken into account when aggregation is used, making it a better measure for traits 
(Epstein & O'Brien, 1985); but because the traits are measured following adversity it is 
theorized that the processes the individual takes part in with the environments affect these 
scores (Bonanno, 2012). The perspective that resilience traits are affected by processes with 
the environment is relevant as the graph in Figure 8 first stabilises when psychological well-
being decreases, and then increases when the scores stabilise. The processes between the 
environment and the person are found to play a role in the first six months for stabilsation of 
the traits, and are found to influence the person after this point.  
Processes are operationalised through effects of time as these happen in time. As noted 
earlier, the relationship between resilience and symptom remission grows stronger over time. 
The reason for this may be that traits of resilience are influenced by processes with the 
environment.  The theory that the resilience scores are influenced by the stages in the 
recovery process as suggested by Andresen and collaborators (Andresen et al., 2003) may 
explain that the resilience scores are not constant entities. The results indicate that as time 
passes, resilience stabilises during the first six months and levels of psychological well-being 
increase after six months. Levels of psychological well-being “bounce back” which is the 
quality of resilience (Borge, 2007; Fletcher & Sarkar, 2013). It is theorized that some of the 
participants are in the stage of moratorium (Andresen et al., 2003) at intake and between 
baseline and at 6-month follow-up. Moratorium might negatively influence the predictive 
value from baseline to 6-month follow-up as this correlation is not statistically significant. At 
6-month follow-up, the participants are stabilising and report less psychological well-being, as 
confusion of the illness has set in. In the second stage, awareness overlaps the first stage and 
the participants are theorized to be in this stage and stages of preparation and rebuilding 
during 6-month follow-up and in the next six months. In the last stage, growth is shown in the 
face of new setbacks. The person has faith in his or her ability to pull through and maintain a 
positive outlook (Andresen et al., 2003). It is theorized that some of the participants have 
gone through these stages in a process over one year and that the resilience traits in the 
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participants makes this process possible; the positive outcome in levels of psychological well-
being are here the outcome in resilience. The participants have also established relationships 
with health-care practitioners and researchers in this project who have up to date knowledge 
of recovery from schizophrenia; interactions with caretakers and researchers comprise another 
element of the environment. High predictive values are observed between single assessments 
of resilience after six months, which is suggested to reflect that the traits have stabilised. This 
might also be indicative of stabilisation of the environment as families and friends become 
used to the illness over time. 
Some of the persons may have lower levels of psychological well-being, which stabilised 
after six months, other persons might be either homeostatic reintegrated with levels of 
psychological well-being similar to the levels before the adversity whereas others might have 
gotten higher levels of resilience (Fletcher & Sarkar, 2013; Richardson, 2002; Richardson et 
al., 1990), in the aftermath of the adversity the schizophrenia represents. The traits were not 
measured in a premorbid state of the illness, so it is hard to conclude how the participants 
would have scored before the onset of the illness (Bonanno, 2012) even though it is theorized 
that the participants would have had higher resilience scores. The participants are suggested to 
be affected by the onset of the illness and the situation they are in, and it is suggested that the 
traits have not stabilised in the period of untreated psychosis. Some patients might be engaged 
in more or less resilient processes enabled both by their traits and the environment prior to 
intake, but, as mentioned previously, these relations are not controlled for and it is therefore 
difficult to draw any conclusions. However, the increasing graph after 6-month follow-up 
reflects the quality to be able to “bounce back” (Fletcher & Sarkar, 2013), through a recovery 
process as suggested by Andresen and collaborators (Andresen et al., 2003) enabled by the 
quality of the resilience traits of the participants (Masten, 2001). As shown, the process 
(Luthar et al., 2000) is an important factor during the first six months and does not disappear 
as time passes. 
Processes in the environment affecting experienced resilience 
Bonanno (2012) noted that resilience is rarely measured as a trait only (Bonanno, 2012); most 
resilience studies measure resilience following a period of adversity, which is also the case in 
this study. Even though there is a theoretical suggestion that the resilience scores would have 
been higher before the adversity, this is not measured and therefore not known. The processes 
the individuals find themselves in are therefore a factor that is suggested to contribute to the 
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measures over the whole period. The graph is suggested to reflect the processes the 
participants are in, as well as underlying traits. Rutter notes that traits themselves are 
changeable; they are not constant entities (Rutter, 1987). Measuring resilience over many 
situations takes the focus away from the situation but actualises the debate between resilience 
measured as a trait or as a process. Nonetheless, the more resilient the person is the higher 
probability the person has to be engaged in processes enabling greater resilience as the more 
resilient persons is suggested to be proactive when choosing relations (Sarkar & Fletcher, 
2014). An example of this might be that patients who underwent longer therapeutic treatment 
demonstrated increased social capability (Torgalsbøen, 2012a); a possible explanation for this 
might be that more resilient persons might have sought out situations with good relations 
which led to more experienced resilience through social relations. Resilience has been 
demonstrated to be modifiable by therapy in disorders such as General Anxiety Disorder 
(GAD) (Connor & Davidson, 2003; Hansen & Thomassen, 2010). Some participants are 
maybe in hostile environments (Ciompi et al., 2010; van Zelst, 2009; Zubin & Spring, 1977) 
where schizophrenia is stigmatized and availability of treatment might be the only thing that 
can meet their degree of hopes, perceived self-efficacy and perceived belief in social support. 
Patients who were more resilient (Masten, 2001) would have chosen to take part in this 
therapy if they found therapists who met their expectations and with who they could form a 
good relationship (Hagen, 2011). If such treatment was not available, and there were no other 
available means of support, the same processes of resilience would not take place, because 






















A person’s traits are influenced by the environment, and environments with more resources 
available foster more resilience (Luthar et al., 2000). Processes between the environment and 
the person are theorized and demonstrated in these results, operationalized as the effects of 
time, to firstly stabilise the scores and then influence them. The relationships between 
processes and traits for resilience which can foster more resilience are shown in Figure 10.  
It is suggested on the basis of the analyses that experienced resilience in schizophrenia is a 
concept involving both resilient traits and resilience processes between an individual and their 
environment. Resilience is suggested to not be a highly stable trait, but to be influenced by 
processes with the environment. Processes within the persons and processes with the 
environment are suggested to be reflected in the resilience scores after the onset of 
schizophrenia. Early in the time-period of schizophrenia, resilience is a more unstable 
construct and is theorized to get affected by the processes with the environment. The 
participants are suggested to be more vulnerable to hostile environments; support received is 
suggested to play a bigger part in this period. After the first six months, the stability of 
resilience increases and levels of psychological well-being increase; this might reflect that 
both the traits and processes are stabilised. Scores of experienced resilience from the patient 
are suggested to give an indication of degrees of resilience traits and degrees of resilience 
processes the person takes part in. How much resilience is experienced by the person gives an 
estimate of levels of resilient traits of the person. An effective method of therapy might be for 
the therapist to tap into these resilient traits in order to foster greater psychological well-being 















in the patient, because psychological well-being has value in and of itself and is found to 
correlate with symptom remission. 
4.1.3 Are degrees of experienced resilience a predictor for symptom 
remission in schizophrenia? 
The logistic regression with variables of experienced resilience over the first year and 
symptom remission measured at 2-year follow-up found that resilience is predictive for 
symptom remission. Participants with high levels of experienced resilience are 13 times more 
likely to be in symptom remission at 2-year follow-up, when controlling for no other 
variables. When controlling for gender, age and years of education in different models, the 
explained variance increased and the models were found to be statistically significant. When 
controlling for age and years of education in different models, resilience was found to be 
statistically significant and had a high odds ratio. When controlling for gender, resilience was 
not found to be statistically significant but had a high odds ratio. When controlling for all 
these variables in the same model, resilience kept its high predictive value, but the statistically 
significant level decreased. In order to control for how degrees of symptoms at baseline 
affected the relationship between resilience and symptom remission, total PANSS-score at 
baseline was controlled for. Controlling for PANSS, the predictive value for resilience 
increased, indicating that resilience is a strong predictor for symptom remission even when 
levels of symptoms are controlled for. Several other logistic regressions were conducted to 
control for tendencies from resilience. Variables of neurocognitive functioning (assessed 
through the MATRICS consensus cognitive battery), social role functioning, professional role 
functioning (Torgalsbøen et al., 2014) medication, type of schizophrenia diagnosis, type of 
education, and other variables were controlled for. These analyses showed a trend towards a 
predictive value for resilience with both statistically significant and non-statistically 
significant results. When many variables are taken into account in one model, the predictive 
value most for resilience often keeps its value while the statistically significant value for 
resilience often decreases to a level of non-significance. This relation suggests that the impact 
of experienced resilience on symptom remission decreases when the bigger picture is 
considered. But even these findings, resilience is shown to play a part on the way to symptom 
remission, as resilience even in these controlling analyses had in general higher odds ratios 
than the other variables. As seen in Table 3, in the method section, there is a large window in 
which the actual odds ratios value might be situated, with a 95% statistical probability, which 
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was a trend in all the analyses. Despite this consideration, the high predictive value of 
resilience is conserved, as several logistic regressions show a trend towards a higher 
predictive value for this variable compared to the other variables measured. In sum, there is a 
trend that participants with high degrees of experienced resilience are more likely to be in 
symptom remission at 2-year follow-up when other variables are controlled for, 
Experienced resilience can be viewed as an indication of psychological well-being and good 
relations to other persons, which reflects qualitative good relations. Although these factors are 
hard to control for, one way to control for them would be to let the therapist, family members, 
friends and the participants themselves rate their relationships with one another and their 
psychological well-being and the psychological well-being of the patient. This would also 
give an indication of resilience processes between the persons and the environment, and 
prospered a window to investigating resilience processes in more depth. As mentioned earlier, 
how persons rate their own levels of psychological well-being and happiness is correlated 
with how other people view these levels for the individual (Larsen & Buss, 2008). Even 
though persons with schizophrenia can have poor insight (McEvoy et al., 1989), it is 
suggested that the score for experienced resilience gives a qualitative rating of actual 
psychological well-being and a nuanced rating of good relations.  
In sum, the results and analyses indicate that experienced resilience is a stable construct which 
is predictive for symptom remission. These results support the research question that degrees 
of experienced resilience is a predictor for symptom remission at 2-year follow-up, and the 
effects are found to be high. These levels of experienced resilience are, as previously 
mentioned, found to be influenced by resilience processes during the first six months, which 
contributed to a stabilisation of the traits. The effect of the processes with the environment did 
not diminish in the next 18 months; however, during this time, the traits were found to have 
stabilised and been less influenced by interactions with the environment.  
 “Given half a chance” 
The findings from the correlations and the logistic regressions both support the research 
questions regarding that experienced resilience is both associated and predictive for symptom 
remission in schizophrenia. The participants in this study were admitted at an early stage in 
their illness to the project with an average of 13.3 months of untreated psychosis, including 
drop-outs (Torgalsbøen et al., 2014). In chronically ill patients, the symptoms are often 
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reoccurring with relapses to the illness. The resilient traits may have enabled a homeostatic or 
resilient reintegration in a process with the environment, where hopes for the future and 
perceived views of good relations are taken into account, but the symptoms themselves have 
not been reduced. Less resilience might also have been enabled, with a lower degree of 
psychological well-being. In persons experiencing high degrees of resilience who are still in 
non-remission, the symptoms might have been harder to differentiate from the person (e.g. the 
person has a strong belief that he is Jesus and has a perceived view of having supportive 
relations). Because most participants are admitted at an early stage of their illness to this 
project, the results found can be generalised to newly diagnosed patients with schizophrenia. 
It is theorized that the participants have higher degrees of resilience than persons who do not 
take contact with mental health care or do not accept an invitation to take part in a study 
emphasizing recovery. One reason why the participants are involved in this research project 
may be that they hold the belief that to attend such a project actually can be beneficial for 
their situation. Relations, through perceived support from others are a part of the resilience 
construct (Bekkhus, 2012; Luthar et al., 2000). Taking part in such studies is voluntary, so 
participants who agree to take part in research might have a higher degree of belief in the idea 
that support from other people is beneficial. As seen by table 1 in the method section, all 
participants were either in-patients or outpatients at baseline assessment; they have all 
participated in treatment or other relations systemised by a health-care system. The 
participants were taking part in processes within a health-care system which can enable more 
resilience if hopes and degrees of resilience were met. More resilient persons enable richer 
resilience processes as they chose to take part in these processes. 
It is theorized that there is a placebo effect created by simply referring to a project as having a 
focus on “full recovery” from schizophrenia, because the implied message to patients is that 
full recovery is possible. The principal investigator and the testers in this project had up-to 
date knowledge about recovery and the concept of a meaningful life. Hope and resilience 
processes within the individual were therefore met (Torgalsbøen, 2011, 2012a, 2012b; 
Torgalsbøen & Rund, 2010) by the environment. Resilience processes are suggested to be 
enabled by both the patient and also the environment; through the research-team, general 
health-care and the family. It is theorized that since positive framing is used both in the 
description of the research and in communication with the participants, this is transmitted to 
the patients by verbal and non-verbal communication. More resilience processes are enabled 
than if this communication process had not taken place (Luthar et al., 2000). Thus it could be 
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said that the participants in this project are “given half a chance” or more (Ciompi et al., 
2010). This may explain some of the high remission rates and the high retention rate found in 
this study which is suggested to have a cumulative effect on experienced resilience. The 
positive outlook on recovery is thought to be greater in this project as the knowledge 
regarding recovery is up to date, as research in the field of schizophrenia concludes with 
higher remission rates than later versions of DSM and ICD are updated with (Ciompi et al., 
2010; DSMPsychiatryOnline, 2014; Hersen et al., 2007; Organization, 1993). If the 
participants had not taken part in this study and had instead entered a treatment system which 
did not have up to date knowledge of remission and recovery, the participants may have taken 
part in lesser resilience processes, as some of them might be dependent on care from health-
care professionals, at least in the early stages of the illness. The participants in this project are 
given a better chance. The suggested cumulative positive effects discussed, show health-care 
at its best and does not contradict the validity of the research. Rather, it can explain some of 
the high retention and remission rates, and may also explain some of the predictive value 
between experienced resilience and symptom remission. To control for this effect would be 
ethically difficult and hard to systemise, but scientifically rewarding, considering the debate 
on the person versus processes.  
There is also a focus on function for the participants in this project where scales for 
professional role function and social role function takes this in to the picture (Torgalsbøen et 
al., 2014). Function is found to be correlated with feelings of psychological wellbeing (Larsen 
& Buss, 2008), so a focus on such elements are also suggested to foster more psychological 
wellbeing. The participants are in a project where their views for a valuable future are shared 
(Torgalsbøen, 2011). This is an example of resilience traits taking part in a process of 
resilience enabled both by the traits and by the environment, giving positive cumulative 
effects. Resilient traits encompass more resilience (Masten, 2001), but the traits cannot be 
seen separately from the environments (van Zelst, 2009; Zubin & Spring, 1977), which can 
provide different kinds of support (Ciompi et al., 2010). It is theorized that the resilient 
participants have been proactive (Sarkar & Fletcher, 2014), and aware of whether these things 
are communicated, and they have therefore taken part and remained in the project, which 
might explain some of the low attrition rate. Some participants might be in highly hostile 
environments (van Zelst, 2009; Zubin & Spring, 1977), which would have enabled less 
resilience had they not sought treatment or joined this study. The participants also meet with 
the principal researcher at least once a year over the course of the year. Positive resilience 
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processes might be enabled by meeting with an interviewer who is familiar to the participant 
(Torgalsbøen, 2012b).  These meetings, including testing with health-care professionals who 
possess updated knowledge on recovery, may actually affect the participants and the situation 
the persons are in (Epstein & O'Brien, 1985), and therefore affect the scores. The situation 
may cause the scores to be more positive as resilience processes are enabled, both by the 
situation and by the participants. This is suggested to have a cumulative process which 
enables more resilience. More resilient persons enable richer resilience processes by choosing 
to take part in these processes. Resilience processes are enabled by the person and by the 
environment, which, according to the results discussed in this thesis, reduces symptoms.  
As the DSM and ICD are not updated with the latest research on the field of schizophrenia 
(Ciompi et al., 2010; DSMPsychiatryOnline, 2014; Hersen et al., 2007; Organization, 1993), 
the findings might be harder to generalize. Other institutions in other parts of mental health-
care might not have the same focus on resilience and recovery and up-to date knowledge 
about actual recovery rates amongst patients with schizophrenia. These results can therefore 
be suggested to be able to generalise to health-care systems with the same amount of updated 
knowledge of recovery and psychological well-being. The results can be further generalised to 













4.1.4 Resilience, vulnerability and symptom remission. 
It is suggested from the findings that there is a higher probability that individuals with traits of 
resilience, which get in to richer resilience processes with the environment, will return to the 
premorbid state of psychological homeostasis. Low degrees of vulnerability traits lead to a 
higher probability to return to a premorbid state of the illness (Zubin & Spring, 1977).  
Figure 11: Factors increasing the likelihood of a positive outcome in symptom reduction. 
 
           Experienced resilience  
High degrees of experienced resilience and low degrees of vulnerability are suggested to be 
predictive for symptom remission; interactions between these factors are shown in Figure 11. 
The construct of experienced resilience permits more nuanced distinctions in the 
understanding of the situation, processes and traits of the person, because it measures degrees 
and gives a richer picture of the person’s current state. The environment consists of diverse 
variables, so even if all factors had been accounted for, the effects of the processes are hard to 
identify. These interactions should be measured with nuanced distinct variables as well, since 
life has a qualitative of being rich in meaning, and constructs measuring the absence or 
presence of different factors does not contain nuanced distinctions. It has not been found 
nuanced measures for other resilience constructs in the data-set which are needed for such 
analyses. Ratings of resilience by both participants and persons in the environment should 
then have been conducted to see how these affect each other. In the absence of such ratings 














processes are present in time. The results and analyses have found that traits and processes of 
resilience make the person more prepared for handling adversities. Experienced resilience is 
suggested to make the person more prepared to cope with stressors and adversities which may 
affect an underlying vulnerability that could facilitate relapses in the condition.  
4.1.5 Self-fulfilling prophecies? 
 “The right of informed consent,” “The right to be informed of test findings” and “The right to 
privacy and confidentiality” (Cohen & Swerdlik, 2010, pp. 66 - 68) were all obtained in this 
study. “The right for the least stigmatizing label” (Cohen & Swerdlik, 2010, p. 69) will be 
discussed in what follows, as this is relevant for resilience. These rights, which are manifested 
in laws and ethical suggestions (Cohen & Swerdlik, 2010), were taken in to consideration in 
this thesis and research. 
 “A succinct statement of resilience is that there is a force within everyone that drives them to 
seek self-actualization, altruism, wisdom, and harmony with a spiritual source of strength” 
(Richardson, 2002, p. 313) This actualizes a debate of ethical considerations in regards to 
dividing participants into different groups according to levels of resilience. As seen in Table 4 
and Figure 13 in the appendix, there are only small differences in the mean that would 
separate the participants into groups of “resilient” and “non-resilient”, if divided on the mean. 
Such a division would be interesting for further research, but because of the low number of 
participants, small differences in the mean, and the related ethical considerations, the 
participants were not divided into two groups. As mentioned earlier, the first postulate of the 
third wave is “a source for actuating resilience comes from one’s ecosystem” (Richardson, 
2002, p. 314). The results in this thesis support this important postulate. It would be hard to 
investigate individuals and not account for the interaction that occurs between the individual 
and the environment; whether this result is mostly affected by the individual or the 
environment is another discussion. An unwanted effect from dividing participants into groups 
of “resilient” and “non-resilient” may be that resilience defined through internal criteria of 
well-being are emphasized more in the “resilient” group. Processes of resilience are then 
made more easily accessible. Persons who are “non-resilient” may be treated in a different 
way, with less focus on the resilient traits, enabling fewer processes of resilience, which in 
turn can affect how the person views him or herself. This hypothesis is also in accordance 
with the resilience literature, which has shifted away from identifying protective factors in the 
individual to study the processes in which the individual participates (Fletcher & Sarkar, 
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2013; Luthar et al., 2000). Bonanno (2012) notes that traits of resilience are debated to be 
measured when resilience is measured after the adversity, it may rather be processes of 
resilience that then are reflected in the scores (Bonanno, 2012). Resilience is measured after 
the adversity in this study. This calls into question the division between the lesser and more 
resilient persons, perhaps reflecting instead that the persons are engaged in more or less rich 
resilience processes enabled by both the traits of the person and the situations they find 
themselves in. Focusing on resilience without having the person and his or her traits in focus 
might be nearly impossible, because the person is the one that interacts with the environment. 
Because of these considerations and on the basis of the results, this study suggests that both 
traits and processes are measured.  









As mentioned earlier, Ciompi, Harding and Lehtinen (2010) expressed their concern 
regarding the pessimistic view on recovery from schizophrenia and noted that findings from 
11 world studies have “shown that persons labelled with prolonged and episodic forms of 
schizophrenia have a strong possibility of favourable long-term outcomes if given half a 
chance” (Ciompi et al., 2010, p. 437). At worst, this can be a self-fulfilling prophecy for 
persons labelled as less-resilient patients. Patients labelled “non-resilient” may not be given 
the same chance. The patients who are viewed as “resilient” may benefit from being viewed 
as such by the treating therapist who might consequently, conscious or unconscious, enable 
more resilience processes to take place. Conversely, the “non-resilient” participants may be 
Less resilience enabled 









viewed as such by their caretakers, thereby enabling fewer resilience processes. In short, less 
resilience is enabled in the “non-resilient” group and these persons therefore have less of a 
chance to take part in richer resilience processes, which can have a consequence on degree of 
experienced resilience. To describe resilience as a continuous variable, which reflects the true 
nature of the scale, instead of dividing the persons into “non-resilient” and “resilient” groups 
might also be more humane; all persons have both advantages and disadvantages because 
resilience is suggested to be a capacity within every soul (Richardson, 2002). One suggestion 
would be to divide participants into groups of greater and lesser degrees of resilience. Other 
attributes, such as cognitive functioning, professional role functioning, social role functioning 
(Torgalsbøen et al., 2014), social competence (Torgalsbøen, 2012a) and degrees of 
vulnerability (Zubin & Spring, 1977) all play a role in the process of recovery. Even though 
all attributes are taken in to account, the levels are merely predictive (DSMPsychiatryOnline, 
2014) and do not determine future outcomes. It is important to be aware of these relations in 
therapy processes and in research, as different processes can be enabled which may enable 
different outcomes, such as more or less resilient processes. The debate regarding having 
vulnerability for schizophrenia versus being schizophrenic (Torgalsbøen, 2012a; Torgalsbøen 
& Rund, 2010) is suggested be equal to the debate of labelling patients in regards to 
resilience. Postulate two from the third wave of resilience summarizes this debate: “Resilience 
is a capacity in every soul” (Richardson, 2002, p. 313). Possible effects of labelling patients as 
“resilient” and “non-resilient” are described in Figure 12. 
Symptom remission (Kay et al., 1987) is chosen even though the division between the 
remission and non-remission groups only represents small differences in levels of symptoms. 
It is important to protect the most vulnerable persons and have a health-care system that takes 
responsibility when persons are not in a state where they can take care of themselves. Because 
many countries in the world use DSM and ICD (DSMPsychiatryOnline, 2014; Organization, 
1993) this method is chosen, as such a division is supported here.. But it is important to keep 
in mind that it is only small differences that differentiate the two groups, and the debate 
regarding what is humane is also relevant here. Vulnerability is another construct that can be 
used to divide participants into vulnerable and non-vulnerable and the same ethical 
considerations are suggested to be accounted for here.  
To declare that a patient is schizophrenic may be a more deterministic and defining phrase 
than to describe the illness in terms of having a schizophrenia spectrum disorder. Declaring a 
patient to be “non-resilient” may be seen in the same way and a more humane approach might 
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be to talk about degrees of resilience, which can predict symptom reduction. If resilience is 
understood to be a capacity within every soul, it is thus suggested that talking about 
schizophrenia in terms of more- and less-rich resilience processes and degrees of resilient and 
vulnerability traits that predict episodes with relapse is a more humane way to conceptualise 
schizophrenia.  
4.2 Limitations and strengths of this study  
Small sample size 
A low statistical power is inevitable with small sample sizes, and the likelihood of making an 
incorrect no-difference conclusion increases (Torgalsbøen, 2012b). The aim of this intensive 
study has been to uncover tendencies in a small patient group. It is harder to generalize from 
intensive studies such as this one, but when significant results are found these can 
nevertheless be generalized for groups that have approximately the same resources available. 
Because resilience is defined through the capacity to rely on relations, there is a theoretically 
high probability that participants with low levels of resilience on a group-level would not 
attend this study as they would not see help from a system as being rewarding. As suggested 
earlier, there can also be a placebo effect resulting from the fact that participants were 
recruited to join the research project; this can have an effect on the resilience scores and 
resilience processes enabled. The implication is that the results can be generalized to in-
patients and out-patients with the same demographic variables as the subjects in this study. 
The high remission rate in this study might indicate that the participants have taken part in 
richer resilience processes enabled not only by their traits but also by the research team. The 
research team have up to date knowledge concerning the possibility of recovery, a focus on 
daily functioning, and a social and professional role (Torgalsbøen et al., 2014) in addition to 
sharing a belief in the value of a meaningful life (Torgalsbøen, 2012a). The participants have 
also taken part in general treatment from health-care professionals, and this is suggested to 
affect the relationship between resilience and symptom remission as well. It is difficult to 
control for these effects, as not giving health-care to a group of patients with schizophrenia to 
see how this affects them is ethically impossible. Controlling for these effects is also hard 
because the placebo effect is theorized to always be present when pertained to a study, and it 
would be hard to find good nuanced variables to control for these effects.  
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Unable to control for qualitative variables and variables of processes 
Considering the low N and the presence of few good nuanced variables in regards to 
resilience measured by others than the participants, it has been hard to control for other 
relations. Qualitative variables and other nuanced variables have been hard to find in this 
project, such variables contain ratings of degrees of different constructs, including alliance 
between the therapist and the patient and levels of expressed emotion in the family and 
environment. Ideally, better nuanced data should be attained, with scales that reflect degrees 
of different variables, in order to differentiate the picture. As noted earlier, variables such as 
age, gender, years of education, and degrees of symptoms, type of education, type of 
schizophrenia diagnosis, medication, neurocognitive ability, social and professional role, and 
other variables that may affect the relationship between resilience and symptom remission, 
have been controlled for. Other variables that might play a role, such as biological and 
physiological factors, life events, racial-ethnic, familial and genetic relations (Hersen et al., 
2007), type of work and kind of treatment given are not controlled for. Other variables not 
controlled for include shifting attitudes and ideologies of the culture, mass media, health 
services, social welfare services, legal services, socio-historical conditions, membership of 
church groups, general health, neighbourhood play area, relationships to neighbours and peers 
(Bronfenbrenner, 1992; Gardiner et al., 1998; Hess & Schultz, 2008)), sexual orientation and 
nationality. To control for the whole picture of the environment and processes another 
research design is needed; therefore an in-depth analysis is not conducted here. Another 
design containing either shorter intervals of time, or intervals over several years containing 
therapy would be needed to further examine the processes between the individual and the 
environments. The alliance between the therapist and the patient could then be assessed 
qualitatively and give a more nuanced picture of the processes in which the individuals 
participate during their treatment. In this study, these processes are operationalized through 
processes of time, as interactions between the individual and the environment take place over 
time (Egeland et al., 1993; Sarkar & Fletcher, 2014); this has given an indication that 
processes play a part in the resilience construct. 
The course of schizophrenia is complex. Low resilience scores are thought to be affected by 
levels of anxiety and depression which are common comorbidities in schizophrenia (Hersen et 
al., 2007) , but these relationships are not controlled for in the present study. High scores for 
resilience can theoretically indicate an absence of depression, which affects psychological 
well-being (DSMPsychiatryOnline, 2014), but even so, depression does not necessarily affect 
59 
 
hope, perceived resilience and self-efficacy. Because manic periods are correlated with 
feelings of happiness and psychological well-being (DSMPsychiatryOnline, 2014; Hersen et 
al., 2007) the mood swings in patients with schizoaffective disorders may also contribute to 
the decreasing and increasing of the graph representing levels of psychological well-being. 
The moods of the participants at the time of assessment are theorized to affect the scores, but 
this effect is suggested to be evened out by aggregation. The quality of paranoid symptoms 
might as well be reflected in the scores as this is suggested to affect the view of other persons. 
Resilience is found to be correlated with and to predict symptom remission, but when the 
sample size is small, there is a greater chance for accepting the hypotheses. Errors of the first 
kind, (e.g. when a correlation between X and Y, leads to a false rejection of the null 
hypothesis) might have occurred (Howitt & Cramer, 2008). There is found statistically 
significant results supporting a relationship and a predictive value between resilience and 
symptom remission, and the null hypothesis is therefore rejected .As many of the correlations 
are only just statistically significant, as reported in the methods section, there is a probability 
in the data-material that the findings are not true and that the conclusion of accepting the 
hypotheses is false. In this thesis, several correlations and logistic regressions with several 
controlling variables are conducted. It was found a trend towards that resilience is both 
correlated with and predictive for symptom remission, thus falsely accepting the hypotheses 
regarding a relationship and a predictive value of resilience is suggested to even out.  
Measurement of resilience 
As mentioned earlier, one possible reason for enabled resilience processes is multiple 
meetings with a familiar interviewer, as confidence can be promoted through familiarity 
(Torgalsbøen, 2012b). Meetings with testers with up-to-date knowledge regarding the 
importance of resilience and the possibility of recovery could play a role in symptom 
remission and recovery. As noted earlier, the resilience traits in this study were not measured 
in a premorbid state of the illness, so it is hard to draw conclusions about how participants 
would have scored before the onset of the illness. Bonanno (2012) noted that most research 
has investigated the effects of resilience after an adversity and has not measured resilience 
traits before the adversity; measuring resilience in this way calls into question the validity of 
resilience as a trait (Bonanno, 2012). However, it is difficult to measure resilience both before 
and after a schizophrenia diagnosis because only one per cent of the population develops a 
diagnosis within the schizophrenia spectrum (Andreassen & Steen, 2011). The processes 
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between the environment and the person are suggested to have an impact on traits and this can 
be reflected in scores and in the correlations with the effects of time. Through the analyses, 
levels of positive and negative symptoms are not found to affect experienced resilience. 
Experienced resilience stabilises during the first six months, which is when most participants 
developed symptom remission. If these relations had been investigated in a state of untreated 
psychosis, it might have been found that the processes and traits of experienced resilience had 
not stabilised. Investigation of these relations would have provided a clearer and richer picture 
in regards to resilience conceptualised as traits or processes in schizophrenia. The differing 
levels of resilience and instability of this trait might be a factor which contributes to the 
illness. This instability is found when the persons are not in symptom remission, and might 
reflect a quality of psychosis. From the analyses it is hard to make a final conclusion in 
regards to the debate if resilience is conceptualised as either a trait or a process, even though 
the correlations indicate that symptom remission does not affect experienced resilience. The 
analyses give support to the view that resilience is conceptualised as both traits and processes, 
as both of them are found present in the construct.  
In regards to accepting the hypothesis if resilience is conceptualised as traits and processes, 
several correlations have been performed to investigate this relationship between traits and 
processes. These correlations have found that the stability of traits differ, they are suggested 
to be affected and influenced by processes with the environment. This is suggested to be made 
able by the processes the participants interact in with the environment, as processes are 
operationalized as effects of time since these processes do happen in time. The instability of 
resilience traits might be effected and as well be a quality of psychosis, but this relation is not 
deepened in to. The shifting focus of the resilience literature from identifying factors within 
the person (Fletcher & Sarkar, 2013; Luthar et al., 2000) and as instruments of personality are 
often used to measure resilience after the adversity (Bonanno, 2012) in lack of other 
instruments, substantiate the finding that resilience is consisting of both traits and processes. 
In particular, the relation that resilience is only measured after the adversity of the onset of the 
schizophrenia illness is suggested to even out falsely accepting the hypotheses regarding 
resilience conceptualised as traits and processes. 
In a larger sample, a factor analysis to control for factors in the experienced resilience 
construct could have been performed.  A factor analysis would might have shown other 
factors than the three measurements suggests, but it is rather the questions together in one that 
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is theorized to reflect the truer nature of the experienced resilience construct. Hence these 
considerations, the validity of the scales are suggested to keep its validity.  
One possible limitation of this study is that the interviewer was not blind to the degrees of 
social and professional function of the participants (Torgalsbøen et al., 2014), and as 
premorbid levels of function are found to predict episodes with relapse (Zubin & Spring, 
1977), this might lead to predictions of recovery status and symptom remission status that 
affect the viewing of the participants. Participants were also able to develop a familiarity with 
the principal researcher over multiple meeting-points, which is suggested to promote 
confidence (Torgalsbøen, 2012b). As noted previously, a good relationship between the 
principal researcher and the patients is suggested to lead to resilience processes and thereby 
symptom remission, as suggested by these results and analyses. These observations do not 
contradict the findings, but rather paint a bigger picture of a supportive environment in which 
individuals interacted during the study. 
High retention rate and multiple assessment points 
The strengths of this study include the use of well-proven instruments and sound 
psychometric measures (Connor & Davidson, 2003; Kay et al., 1987; Schwarzer & Jerusalem, 
1995; Wahl et al., 2004), structured interviews (Torgalsbøen, 2012b) and very low attrition 
rate. The high retention rate makes it easier to control for multiple variables at different time-
points; this strengthens the study and may contribute to statistically significant results, which 
can then be generalized to persons and environments with the same attributes and resources 
available. Important relations regarding the relationship and predictability of resilience on 
symptom remission and what resilience consists of are found. This contributes to a deeper 
understanding of the relationship between experienced resilience and levels of positive and 
negative symptoms. Traits and processes of resilience are found to be predictive for symptom 






4.3 Clinical implications and future research 
It is proposed that the results can be generalized to situations and health-care systems where 
the same amount of updated knowledge and a similarly positive outlook for the future is 
present, as well as to therapy processes where there is a good underlying alliance between the 
therapist and the patient. It is further suggested that the results may be generalized to 
situations and environments with the same resources, to persons with the same degrees of 
resilient traits and to persons who are admitted to mental health-care at an early stage, 
compared to persons with more chronic conditions.  
Clinical implications 
Because single assessments of resilience is strongly correlated to aggregated resilience, a 
single assessment of resilience gives an indication of resilience traits and processes, which in 
turn gives an indication of degrees of resilient traits of the person. An approach for clinical 
practice is therefore to identify processes within the person and in the environment that enable 
the person to take part in richer resilience processes. Identifying these resilience processes and 
then trying to tap into the patient’s resilient qualities is suggested as a method for professional 
clinicians working with schizophrenia, as this resilience is found to be predictive for symptom 
remission. If met by an underlying good alliance with the clinician or persons in the 
environment, the resilient part of a person can contribute to greater psychological well-being 
that has a value in itself. This level of psychological well-being is found to be predictive for 
symptom-remission, which can lead the way to recovery from the illness. As resilience is a 
capacity within every soul (Richardson, 2002), it is suggested that trying to make an alliance 
with this part of the person with schizophrenia in order to foster more experienced resilience 
in both more- and less-resilient persons has a value in and of itself, because it can foster 
greater psychological well-being. 
Future research 
A possible direction for further research based on these findings would be to explore whether 
having positive and negative symptoms are correlated with unstable resilience traits, and 
whether degrees of symptoms affect degrees of resilience. Further research on interactions 
between resilience and vulnerability traits should also be assessed, as these interactions are 
suggested to affect each other and found to affect symptom remission. Other directions for 
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further research suggested to be by this study include research on degrees of resilient traits as 
predictive for symptom remission and full recovery, and research on resilience processes 
leading to these outcomes should be conducted, and research identifying what are these 
processes that foster more experienced resilience should be conducted. Additionally, 
investigating the effects of the environment on the stability of resilience and vulnerability 
traits should be conducted. Resilience has a somewhat self-fulfilling quality integrated in its 
construct, as adversities are always present in resilience. If adversities are taken away, the 
resilience construct is no longer present. Further research identifying processes in which can 
lead to life-courses with fewer adversities for patients with schizophrenia should therefore be 
conducted.   
In sum, a focus on resilience processes, for example as described by individuals who have 
published accounts of their own recovery processes (Andresen et al., 2003), would have 
potentially important clinical and research implications. This is because resilience, in this 
thesis, is conceptualised through the description of these recovery processes, as described by 
the persons themselves (Andresen et al., 2003), and this resilience is found to be predictive for 
symptom remission. By focusing on the positive processes within the individual (Masten, 
2001) and the dynamic processes between the individual and environments (Luthar et al., 
2000) it may be possible to increase experienced resilience in therapy. How to enable these 
processes in therapy for schizophrenia is an important question for further research and in 
general therapy. The resilience construct consists of both adversity and positive adaption and 
therefore may be a limiting way of viewing an individual; in this view, if the adversities are 
no longer present, neither is resilience. In schizophrenia there are many comorbidities and 
adversities present (Hersen et al., 2007). For this reason, identifying processes which lead to 
experienced resilience, and identifying processes in which individuals can diminish stress and 
adversity in their lives are important for further research and in treatment of schizophrenia. 
Experienced resilience is then a helpful quality in new situations with adversities and 
stressors, although the adversities do not stress the person in the same way when they are no 
longer present in high degrees. Working with life-courses with multiple adversities implicates 
longer treatment courses, which is in concordance with general suggestions for therapy for 
persons with schizophrenia spectrum disorders. Working to increase experienced resilience is 
suggested to be a method which can foster more experienced resilience, is suggested to be a 





DSM-V notes in regards to schizophrenia spectrum disorders: “The predictors of course and 
outcome are largely unexplained, and course and outcome may not be reliably predicted” 
(DSMPsychiatryOnline, 2014). Comments like these show the importance of investigating 
correlations between recovery and various constructs that are suggested to improve recovery 
in schizophrenia. In order to deepen understanding of these relations, this thesis has examined 
the hypothesis that resilience can foster symptom remission (Torgalsbøen, 2012a). 
Is there a relationship between degrees of experienced resilience and symptom 
remission in schizophrenia at 2-year follow-up? 
Experienced resilience over one year is found to correlate with symptom remission at 2-year 
follow-up. Single assessments of resilience predict symptom remission later on in a few 
correlations, but the opposite is not found to be the case. Symptom remission is found to 
predict symptom remission later. The implication of these results is that experienced 
resilience over one year is correlated with and predictive for symptom remission, which, in 
turn, is predictive for sustained symptom remission. On the basis of these results, a 
relationship is established between resilience and symptom remission, specifically that 
resilience may foster symptom remission. 
Is experienced resilience in schizophrenia a concept involving both resilient 
traits and resilience processes between the individual and the environment? 
The results from this thesis show that resilience is a construct that comprises both traits and 
processes within persons with schizophrenia. The resilience scores stabilise during the first six 
months after admission to health-care in the study, and the average duration of untreated 
psychosis before intake is 13.3 months for the participants (Torgalsbøen et al., 2014). On this 
basis, it is suggested that processes within the individual and between the environment and the 
individual while in health care are important, especially in the first six months. Processes 
involving hope, good relations and enhancement of self-efficacy are suggested to enable a 
positive stability of traits with an increasing curve for psychological well-being from 6-month 
follow-up. The continuous increasing curve is found to be affected by processes with the 
environment as longer intervals of resilience correlations are not statistically significant. 
Experienced resilience appears to be a continuous phenomenon in schizophrenia. The 
processes with the environment are important for the stabilisation of resilience traits in the 
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first six months; the effect of the environment is seen to decrease after this. Because resilience 
is measured after the adversity (Bonanno, 2012), the processes between the environment and 
the person might be reflected in the whole time period of assessments, and it might be that it 
is the processes that have stabilised after some time. Based on these observations, experienced 
resilience in schizophrenia can be conceptualised as consisting of traits which both affect and 
are affected by processes with the environment and within the person. 
Are degrees of experienced resilience a predictor for symptom remission in 
schizophrenia? 
Aggregated resilience is found to predict symptom remission at 2-year follow-up. Even when 
other variables have been controlled for, resilience is found to have a high predictive value. 
When more than one variable is controlled for, resilience is still found to have an effect on 
symptom remission, but the statistically significant value decreases. The measure for 
resilience has nuanced distinctions, and when controlling for several other variables that are 
less nuanced, in one analysis, the effects from resilience decrease. It is possible that if other 
nuanced variables had been controlled for (e.g. controlling for resilience processes in the 
environment), this decreasing relation would not have been found, but as this study does not 
contain such variables this is not investigated. The resilience measure gives an indication of 
qualitatively experienced resilience for the participants, which indicate levels of support from 
the environment. As psychological well-being is found to be measured best by persons 
themselves (Larsen & Buss, 2008), it is suggested that if resilience was correlated to how 
persons in the environment would have scored the persons in regards to resilience, the levels 
of psychological well-being would correspond. In sum, experienced resilience, defined 
through traits and processes, are found to have a predictive value for symptom remission. 
To conclude 
Experienced resilience, measured over one year, is found to correlate with and predict 
resilience score and symptom remission at 2-year follow-up. As the resilient traits have not 
stabilised when many persons are still labelled as non-remission, suggests that resilience can 
be influenced by a supportive environment in health-care, when the persons are in non-
remission in the early stages of the illness. Enhancement of experienced resilience is found to 
be predictive for symptom remission (an example can be through avoiding potentially 
detrimental labels). An important question for further research is to find out how these 
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processes can be enabled. It is suggested that even in severe adversity, it is possible to 
contribute to future benefits by increasing the propensity for resilience (Seery, 2011). On the 
basis of these results, it can be stated that acquiring greater degrees of resilience is important 
for persons with schizophrenia. To have a focus on the resilience processes within the 
individual and processes between the individual and the environment is suggested to be a 
focus for health-care professionals working with persons with schizophrenia. If resilience is 
recognized as a capacity existing within every soul (Richardson, 2002), such a focus can be 
achieved through mapping degrees of resilience in individual patients, and tapping into the 
resilience of each patient. A suggestion for further research and for clinicians is to identify 
processes which lessen adversity in schizophrenia, as schizophrenia is found to consist of 
multiple adversities (Hersen et al., 2007). Therapists might work towards enabling 
experienced resilience to be an ongoing continuous phenomenon, including processes within 
the person and processes between the person and the environment, as this is found to predict 
symptom remission. When a person reduces the amount of adversity they face in their life, the 
quality of resilience is less needed; however if new adversities present themselves, the person 
has an integrated understanding of these processes if enabled earlier on. They have then a 
heightened chance to make use of the “bouncing back” quality if needed and a positive 
psychological outcome can be enabled.  On the basis of the findings in this thesis, focusing on 
degrees of experienced resilience in therapy for persons with schizophrenia is a method which 
can promote a good outcome for patients with schizophrenia, in regards to psychological 
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Figure 13: Distribution of the aggregated resilience scores in standard deviation for T1, T2 and T3 (N=25) 
 
APPENDIX II 
Figure 14: Q-Q plot for aggregated resilience (N = 25) Expected value (Y) * Observed value (X) 
 
Note Y = Expected value * X = Observed value 
APPENDIX III 
Table 4: Outlier analysis of the resilience measure (n = 3) 
  Statistic Standard Error 
Mean  -0.06 0.12606 
95 % Confidence interval for 
mean 
Lower bound -0.3182  
Upper bound 0.2022  
5 % Trimmed mean   -0.0622  
Median  -0.07  
 
72 
 
 
